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FEBRILE SEIZURES 
 
Febrile seizures are the most common convulsive events in early childhood, and are defined 
as seizures occurring during a febrile illness in children between 3 months and 5 years of 
age, without evidence of intracranial infection or other neurological conditions (e.g. history of 
unprovoked seizures or chronic anti-epileptic medication).1 
Although considered benign in most cases, a febrile seizure is a frightening experience for 
those who witness it.2 As well as providing acute care to the convulsive child, physicians 
frequently have to reassure parents and bystanders of the generally favorable outcome. 
However febrile seizures recur in about one third of all children who contract a first febrile 
seizure, and it is generally accepted that children with febrile seizures have a four- to five-
fold increased risk of acquiring unprovoked seizures compared to children without a history 
of febrile seizures, especially in those with recurrent febrile seizures.3-5 Therefore it would be 
a source of relief for the caregivers to know whether these recurrences are preventable. 
Unfortunately the pathogenesis of febrile seizures is poorly understood and for each child 
uncertainty persists about progression of the disorder.  
Fever has long been held responsible for the occurrence of febrile seizures. However from 
the current literature it is obvious that febrile seizures are predominantly triggered by viruses, 
whereas bacterial infections, in spite of causing comparable temperature levels, are 
infrequently involved in febrile seizures. Moreover prophylaxis with antipyretics has never 
been proven to be effective. Therefore it is unlikely that fever is the only player in the field, 
and other, currently unknown, pathogenic mechanisms have to be considered. 
 
The discovery of the new human herpesviruses type 6 (HHV-6) and type 7 (HHV-7) has 
renewed the discussion of the pathogenesis of febrile seizures. These two viruses, 
responsible for about one third of initial febrile seizures, have occasionally been detected in 
the cerebrospinal fluid of children with febrile seizures.6;7 From these studies a picture has 
emerged showing that: 
• febrile seizures may be directly induced by virus activity in the brain during primary 
HHV-6 infection 
• HHV-6 may reactivate in the brain and 
• HHV-6 infection of the brain may be associated with recurrent febrile seizures.  
 
 14  
 
INITIATION AND AIMS OF THE STUDY 
 
At the start of this study we hypothesized that viruses (particularly HHV-6 and HHV-7) may 
cause febrile seizures in a more direct way by means of their neuroinvasive properties, with 
a presumptive role in the context of recurrent febrile seizures. Consequently we considered 
that either specific treatment of these infections or prophylactic measures might reduce the 
number of recurrences, and perhaps thereby improve the unfavorable outcome of 
unprovoked seizures. 
The study described in this thesis was initiated to answer the following questions: 
• what are the infections that contribute to febrile seizures? 
• do these pathogens invade the brain (i.e. are they present in the cerebrospinal fluid)? 
• does reactivation of the new human herpesviruses in the brain contribute to febrile 
seizures? 
• are recurrent febrile seizures related to a specific type of infection? 
 
STUDY APPROACH 
 
To achieve the aims of our study we needed access to children with febrile seizures and 
whose cerebrospinal fluid was available for analysis. Pediatricians in the hospitals in the 
northern Dutch province of Friesland were asked to include all patients with febrile seizures 
when a discretionary lumbar puncture was performed. From the beginning it was recognized 
that this approach had a serious drawback of selection bias towards a severe presentation. 
For ethical reasons, cerebrospinal fluid was only available when the clinical presentation 
warranted an additional diagnostic work-up, including a lumbar puncture.8 Moreover children 
with simple febrile seizures were not admitted at all, because this type of seizure is 
considered as benign and, according to a national consensus guideline of the Dutch College 
of General Practitioners, hospital admission is not necessary.9 To circumvent this problem 
we simultaneously initiated a prospective population-based study among all general 
practitioners in Friesland in order to obtain information on the clinical spectrum and the 
incidence of febrile seizures in the total cohort from which the hospitalized children were 
derived. 
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OUTLINE OF THIS THESIS 
 
Chapter 1 presents a general introduction and description of the aim of the study. Chapter 2 
discusses the current knowledge of the pathogenesis of febrile seizures, with emphasis on 
the role of particular infectious agents. Therefore we reviewed the literature on several topics 
related to febrile seizures, i.e. fever, heredity, and the role of cytokines, all of which seem to 
be crucial in the induction of fever. Moreover we reviewed the contribution of specific kinds 
of infections, especially newly identified agents.  
Chapter 3 presents the results from a laboratory-based study of patients admitted to hospital 
with a complex febrile seizure. Bacteriological, virological, serological and molecular 
diagnostic techniques were used in order to investigate the spectrum of microbial agents in 
children eligible for this part of the study. In addition we investigated whether these 
pathogens were present in the cerebrospinal fluid during complex febrile seizures.  
In Chapter 4 we present the results of a population-based survey carried out among general 
practitioners in Friesland from April 1998 to April 2002. The aim was to assess the incidence 
of febrile seizures in the cohort of children at risk for febrile seizures and to investigate the 
involvement of viral infections in febrile seizures. Therefore we calculated the incidence of 
febrile seizures in the general population of Friesland and compared these data with the 
incidences of several common viral infections, obtained from a national registry. This cohort 
study also enabled us to analyze baseline characteristics of febrile seizures in the general 
population.  
Chapter 5 describes a study on the possible role of influenza virus, HHV-6, and HHV-7 in 
Caucasian children suffering from influenza-associated encephalopathy. Influenza viruses 
have been detected sporadically in the brain or cerebrospinal fluid of cases with neurological 
manifestations during influenza, suggesting a pathogenic role by neuroinvasion, but studies 
on this topic have remained inconclusive. Alternatively, it has recently been suggested that 
influenza may trigger the reactivation of HHV-6 and/or HHV-7 within the brain of children 
with influenza-associated encephalopathy.10 Cases with influenza-associated 
encephalopathy were recruited at two microbiological laboratories during two consecutive 
influenza seasons. Cerebrospinal fluid samples were tested by polymerase chain reaction 
for the presence of influenza virus, HHV-6 and HHV-7.     
Chapter 6 presents a case history of a boy with three consecutive febrile seizures within a 
period of four months. A viral etiology could be confirmed for each febrile seizure. 
Progression of severity of illness was observed with each recurrence. Follow-up revealed 
several other recurrences, with the subsequent development of unprovoked seizures despite 
the prophylactic use of antiepileptic medication. In this chapter we discuss the role of 
recurrent febrile seizures in unprovoked seizures.  
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Chapter 7 describes the preliminary results of a follow-up study among children that were 
included with an initial febrile seizure in the population-based study on febrile seizures.  
A 2-year follow-up of these children was completed on a pre-determined end date. The aim 
was to investigate the association of several characteristics of febrile seizures with risk of 
recurrence. Risk factors that were analyzed were age at first febrile seizure, family history of 
either febrile or unprovoked seizures, type of first febrile seizure and the seizure-free interval 
between the first febrile seizure and the first recurrence.  
A summary and general discussion (in English and Dutch) are presented in Chapters 8 and 
9. These chapters end with general conclusions and remarks, as well as suggestions for 
new studies on this topic. 
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SUMMARY 
 
Although fever is regarded as the main trigger in the pathogenesis of febrile seizures (FS), it 
is not supposed to be the unique causative factor. In FS, there is a strong familial 
predisposition. This does not exclude infections as a causative factor because subtle genetic 
polymorphisms have been demonstrated to affect the course of infections.  
We review the literature on: (1) the role of fever, especially the height of temperature, its 
cause, and metabolic effects induced by temperature; (2) the role of heredity; (3) the role of 
cytokines which play a role in the induction of fever; and (4) the role of type of infection, with 
emphasis on newly identified agents and improved diagnostic techniques. With modern 
molecular techniques such as PCR, viruses have been detected in the CSF far more often 
than previously thought, even in the absence of pleocytosis of the CSF. This makes it 
difficult to distinguish FS from acute encephalitis. FS may be caused by neuroinvasion or 
intracerebral activation of viruses. Further studies should focus on these options because 
therapeutic intervention is possible and may prevent late sequelae such as recurrent FS and 
subsequent epilepsy. 
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INTRODUCTION 
 
Febrile seizures (FS) are considered to be relatively benign epileptiform attacks induced by 
fever occurring in young children.1;2 Up to the age of 6 years 2% to 5% of all North-American 
and West-European children will suffer from at least one FS with recurrences in 30%-40% of 
these children.2-5 
Observation of a FS is a frightening experience for the parents and care-givers who 
sometimes think the child will die.6-8 The great majority of FS, however, are medically 
benign. Two-thirds present with simple manifestations and general practitioners are 
instructed to reassure the parents in such cases and to keep the child at home.9 However, 
when FS proceed for more than 15 min, recur within 24 h or show focal signs, a more 
serious condition might be present such as meningitis or encephalitis. Such so-called 
atypical (or complex) FS warrant further analysis in the hospital but in many cases a specific 
cause is not found and uncertainty remains about the prognosis of the child, in particular the 
risk of subsequent epilepsy.1;3;10-13  
Fever per se has been held responsible for inducing FS. Although intensive studies have 
been performed to unravel whether FS could originate from infections, the diagnosis of FS is 
still made by exclusion of other causes, especially infections of the CNS. 
With the availability of newer diagnostic techniques like PCR it has been shown that 
previously non-culturable or fastidious organisms could be detected in brain tissue and 
CSF.14-17 HHV-618 and HHV–719, which do frequently cause FS, have been detected in the 
CSF by PCR, even without a cellular reaction in CSF.20-25 These observations give rise to 
the question whether infectious agents do play a causative role in FS by invading the CNS.26 
Topics that will be reviewed are: (1) fever, with special emphasis on the height of 
temperature, its cause, and metabolic effects induced by temperature; (2) heredity; (3) 
cytokines, which play a role in the induction of fever; and (4) the type of infection. Special 
attention will be given to newly identified agents and the improved diagnostic techniques, 
which support a possible role of invasion of the CNS by infectious agents as a direct cause 
of febrile seizures. 
 
THE ROLE OF FEVER 
 
It is generally accepted that fever plays a major role in FS by triggering an epileptiform 
excitation in the brain. Initially, it was accepted that a steep increase of temperature, instead 
of temperature height, was crucial for the occurrence of FS.27 This assumption was based on 
experiments in which kittens were exposed to hyperthermia.28 Fever, however, differs from 
hyperthermia with respect to the mechanisms responsible for the rise of body temperature 
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and by the different responses of the body regulated by the hypothalamus.29 In fever, the 
body is adapting to a new set point and will retain or generate heat to raise the body 
temperature. In hyperthermia, the body temperature is increased above its set point and the 
body responds, e.g. by sweating, to bring the temperature down to the set point.30;31 In a 
similar study, Millichap chemically induced a raised temperature and showed that there was 
no relationship between the rate of rise in temperature and risk of FS.32 Later studies 
confirmed that a correlation exists with height of fever rather than with the rapidity of the rise 
in temperature.13;29;33-35 
The susceptibility of infants and young children to FS as well as non-febrile seizures has 
been attributed to immaturity of the child’s brain.2;36-39 The susceptibility to seizures, 
frequently designated as seizure threshold, varies between individuals and is higher in the 
very young and in the elderly. The seizure threshold can be defined as a delicate balance 
between neuronal excitation and inhibition. Disturbance of this balance has been proposed 
as a concept to explain how severe systemic illnesses can trigger seizures in critically ill 
patients.40 It has been shown in rats that experimentally induced hyperthermia correlates 
with an increase of the cortical concentration of glutamate and a decrease in seizure 
threshold.41 The effects of gamma-aminobutyric acid (GABA) are even more complex; 
although primarily an inhibitory neurotransmitter, it can counteract its own inhibiting effect 
thus leading to excitation. Either form of imbalance can therefore lead to seizures.42 In young 
rats that had been exposed to hyperthermia, Chen et al. demonstrated an increased 
GABAergic inhibition in the hippocampus, which might be mediated by stimulation of cAMP-
dependent protein kinase.43  
If fever by itself is able to induce a convulsion, one would also expect convulsions to occur 
frequently in subjects who suffer from one of the (familial) hyperthermic syndromes like 
malignant hyperthermia (MH), hyper-IgD syndrome and familial Mediterranean fever. The 
height of fever in these hyperthermic syndromes is comparable to temperatures in FS.44 
Surprisingly, no cases of hyperthermia-related seizures have been reported in the literature 
so far. 
In conclusion, the height of fever correlates with the risk for FS, but it seems unlikely that 
fever as such is the single causative factor in the induction of FS. The susceptibility to 
seizures, otherwise designated as seizure threshold, seems to be influenced by intracranial 
metabolic changes, in particular those of glutamate and GABA. These processes might be 
induced by fever.  
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HEREDITY  
 
Familial predisposition is a well recognized risk factor in epilepsy as well as in FS.45-50 For 
FS, incidence-rates in first degree relatives have been found to vary from 17% to 31%.4;46;49 
The risk of acquiring FS is about 1:5 when a sibling is affected and increases to 1:3 when 
both parents have suffered from febrile convulsions as well.51 A study in monozygotic twins 
showed concordance for FS in 80% of cases.52 In 46 twin pairs, Tsuboi and Endo 
recognized concordance in 18/26 (69%) monozygotic twins compared to 4/20 (20%) in 
dizygotic twins (p<0.01).53  
In probably the first study on this topic, Wallace noticed that a positive family history seems 
to be of no significance in the development of complex FS. Only a combination of both a 
positive family history and perinatal abnormality significantly increased the risk for complex 
FS.54 Perinatal complications that predispose to FS were published in an earlier study.55 In 
contrast, a large cohort study published by Verity et al. in 1985 showed that a positive family 
history was encountered more frequently in children with complex FS compared with 
children with simple FS (p<0.01).4 These two studies, both originating from Great Britain, 
show two striking differences in study performance which may have influenced the outcome. 
First, compared with the NIH Consensus definition of a complex FS (more than 15 min 
and/or more than one seizure in 24 h and/or focal signs), which was used by Verity et al., 
Wallace considered a prolonged FS as complex only when the convulsion lasted for more 
than half an hour. Second, in 62 of the 290 children of the cohort study of Verity et al. a 
family history was not documented.4 These children were therefore not included in the study 
which might have influenced the results. Subsequent studies continued to produce 
conflicting results.53;56-58 
In epilepsy more than 160 Mendelian disorders have been identified, most of them being 
autosomal recessive in origin.37;59 Since epilepsy is a heterogeneous condition there will be 
no single mode of inheritance. In FS different modes of inheritance have been proposed but 
they seem to be multifactorial in origin rather than dominant or recessive.13;51 Recently, 
however, genetic linkage has been detected to chromosome 8q13-21 and chromosome 
19p13.3, respectively.60;61 A rare but distinct entity is the so called “generalized epilepsy with 
febrile seizures plus”, described for the first time in 1996.62 This syndrome is characterized 
by multiple FS in early childhood followed by afebrile convulsions as well as convulsions with 
fever continuing after the age of 6 years. The gene was mapped to chromosome 19q13. 
Recently another locus (2q21-q33) has been identified in a large French pedigree.63 Despite 
increasing proof of defined genetic disorders in FS, most cases are still unexplained. 
However, it seems plausible that other genetic cases will be found in the near future. 
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Because of the possible relationship between FS and infections, several studies suggest that 
there may be a relationship with specific HLA haplotypes.57;64;65 However, these studies refer 
to small series of patients. The overall opinion still is that there is no specific HLA-
linkage.65;66 More subtle polymorphisms such as single amino acid changes in HLA 
molecules, which for example can affect the course of HIV infection, are not excluded by 
such studies.67 Besides HLA, a plethora of new genetic polymorphisms are being unraveled, 
such as polymorphisms in Fcγ receptors68, Toll-like receptors69, as well as cytokines70;71, 
chemokines72;73, or their receptors, all of which involve innate immunity and affect the course 
of infections. A nice example is the polymorfism in the IL-1β gene which may be responsible 
for the genetic susceptibility to epilepsy and prolonged FS.71 
We conclude that the genetic make up plays a decisive role in the development of FS. The 
exact nature by which genes are linked to FS is still largely unknown. Congenital disorders 
with FS have recently been described, but are still sporadic in number. Despite intensive 
research on the topic, the relation between a positive family history and complex FS remains 
inconclusive. 
 
ROLE OF CYTOKINES 
 
The febrile response is mediated by pyrogens produced by activated host cells, and are 
called endogenous pyrogens (EP) or pyrogenic cytokines. Activation of these host cells is 
induced or augmented by several external factors, termed exogenous pyrogens.74;75 Mainly 
of microbial origin, these exogenous pyrogens include cell wall components of either Gram-
negative (lipopolysaccharide (LPS)) or Gram-positive bacteria (peptidoglycan and muramyl 
peptides), bacterial toxins, fungal mannan and glucan components as well as (viral) double-
stranded RNA.76 Numerous cytokines are involved in inflammatory responses. Tumor 
necrosis factor-α (TNF-α), interleukin-1 (IL-1α and IL-1β), interleukin-6 (IL-6) and interferon-γ 
(IFN-γ) are particularly involved as pyrogenic cytokines and play a role in the complex 
system of temperature regulation.77-80 
An area called the preoptic region, which is located in and near the rostral hypothalamus, 
plays a major role in the thermoregulatory process.75 The preoptic region is part of a 
complex hierarchical network together with brain stem and spinal cord. The preoptic area 
contains neurons that are sensitive to subtle changes in hypothalamic or core temperature. 
The preoptic region also receives signals from thermoreceptors throughout the body, 
including warm and cold receptors in the skin, which send their signals via the lateral 
spinothalamic tract to the preoptic region. In this manner, the preoptic region can compare 
 25  
 
peripheral and core temperatures with each other and keep control over the output of 
thermoregulatory responses.81  
It is suggested that EP affect the thermosensitive neurons in the preoptic region. EP are too 
large, however, to penetrate the CNS through the blood-brain barrier by simple diffusion. It 
has therefore been proposed that EP are actively transported through the blood-brain 
barrier, or alternatively that EP can trigger “sensory elements” in or near the organum 
vasculosum laminae terminalis (OVLT), which subsequently transduces the signal because 
the OVLT lacks a blood-brain barrier.82 Recent experiments have shown that the cells that 
make up the blood-brain barrier bear receptors for IL-1β. Intravenous injection of IL-1β 
induced cyclooxygenase-2 (COX-2) and prostaglandin E synthase in these cells, which 
means that they can synthesize prostaglandin E2 (PGE2).83 The latter substance is lipid 
soluble and can pass cellular membranes thus entering the brain. Within the brain, PGE2 
can increase neuronal excitability and it can activate the synthesis of IL-1β by microglia, 
thereby explaining how cytokines can be found within the CNS in response to a systemic 
event.83-85 Although several pathways have been proposed by which EP, such as IL-1β, may 
act at the level of the CNS, PGE2 is supposed to be the major substance transducing signals 
into the brain. PGE2 may for instance be released from the OVLT and directly reach the 
preoptic region by passing the blood-brain barrier.76;81 The most direct pyrogenic pathway 
appears not to be humoral, through circulating cytokines, but is supposed to be of neuronal 
origin (see figure 1A). It is thought to be mediated by hepatic vagal afferent neurons, and 
passes via a noradrenergic dependent cell group, along through the ventral noradrenergic 
bundle to the preoptic region.82;86;87 This neuronal pathway, in which PGE2 is involved as 
well, does better explain the rapidity of the first phase of the biphasic febrile response, which 
cannot be evoked by cytokines because their synthesis will take more time. The second 
febrile phase (see figure 1B), however, may be caused by cytokines.82;87 Whether fever 
arises from the classical cytokine pathway, from vagal afferent neuronal stimulation, via 
alternative pathways or perhaps through multipathway mechanisms, PGE2 seems to be the 
central mediator. Accordingly, PGE2 concentrations fluctuate with the rise and fall of body 
temperature.76;82  
In CNS infections, the local (intracerebral) inflammatory reaction is mediated by cytokines as 
well. IL-1 and TNF-α can be produced inside the CNS by astrocytes, microglial cells and 
endothelial cells.88-90 In mice it has been demonstrated that microglial cells and astrocytes 
secreted IL-6 when infected with vesicular stomatitis virus, which causes a T-cell 
independent acute encephalitis.91 The pyrogenic cytokines show elevated concentrations in 
CSF of patients with infections of the CNS, such as bacterial meningitis and acute 
encephalitis.92-99 In bacterial meningitis, TNF-α, IL-1, IL-6 and IL-8 appear in the CSF early, 
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Figure 1: (A) The first febrile phase (POA = preoptic region of anterior part of the hypothalamus; NST 
= nucleus of solitary tract) and (B) the second febrile phase within the organum vasculosum laminae 
terminalis (OVLT) 
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prior to the increase of leucocytes, supporting the release of these products by cells in the 
CNS.99 High levels of cytokines in CSF have been correlated with neurological 
complications, including seizures.99-101 
Now, knowing all these new hypotheses in the pathogenesis of fever, is there a clue to the 
pathogenesis of FS? According to the NIH consensus on FS (1980) no signs of intracranial 
infection may be present in patients with FS, leaving either fever due to extracranial 
infections or intracerebral infections without signs of inflammation in the CSF as a potential 
source of FS.1  
A clear pleiocytosis in CSF suggests an infectious cause. However, in atypical seizures as 
well as in encephalitis, patients often lack pleiocytosis in CSF which makes it difficult to 
differentiate between the two. Furthermore, it has been shown in children with FS that 
proinflammatory cytokines in CSF are either undetectable or present at similar 
concentrations as found in blood, whereas in children with encephalitis, regardless of the 
absence or presence of a cellular reaction in the CSF, intracerebral cytokine production is 
common.102;103 The encephalitic symptoms probably are caused by intracerebral cytokines 
either produced by penetrating T-cells, or by cells not belonging to the T-cell compartment 
like microglial cells and astrocytes. To play a role, cytokines have not necessarily to be 
detected in the CSF, because they can remain membrane-bound, but still be highly active.76 
Recently it was demonstrated that neopterin levels were significantly elevated in the CSF of 
patients with FS, compared with patients either with pyrexia but without convulsions or with 
nonfebrile convulsions.104 Neopterin is mainly produced by activated macrophages, but also 
by microglial cells. The presence of neopterin in the CSF of FS patients, but not in CSF of 
patients with pyrexia only, therefore supports a causal role for intracerebral inflammation.  
In conclusion, cytokines do play a pivotal role in the induction of fever, probably via multiple 
pathways. Their role as local mediator of inflammation is clear for intracerebral infections 
because intracerebral concentrations correlate strongly with clinical symptoms as well as 
with seizures. In FS, however, signs of intracerebral infection are by definition absent and 
cytokine levels in CSF are usually not elevated. In this regard neopterin is an exception but 
its role in FS needs to be further elucidated. The recent studies of Ek et al. and of Samad et 
al. indicate that cytokines are produced within the brain, also in response to a systemic 
inflammatory reaction.83;84 Hence, a role of cytokines in FS cannot be excluded. 
Alternatively, cytokines can induce PGE2 in cells of the blood-brain barrier, thus transmitting 
a PGE2 response into the brain, which may provoke FS. Further experiments are needed to 
resolve this issue.  
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THE ROLE OF INFECTIOUS AGENTS  
 
Studies in the pre-PCR era 
In 1956 Möller stated that illnesses like exanthem subitum (roseola infantum) cannot cause 
convulsions merely through fever, but that there must be a specific cerebral disturbance 
occurring at the same time related to the type of infection.105 The main argument was that 
children with moderate temperatures could develop FS whereas children with diseases 
causing high fever (e.g. bronchopneumonia and pyelitis) rarely suffer from convulsions. 
Thus, besides fever, the type of infection seems to matter as well. Most children with FS 
show signs of upper respiratory tract infections (otitis, tonsillitis), which in the majority are 
presumed to be of viral origin. With the exception of gastroenteritis (bacterial as well as 
viral), no other overt infectious disease syndromes have been correlated with FS so far.106-110 
However, this association with FS may be biased by geographical differences between 
studies because FS related to gastroenteritis were predominantly reported from countries 
with a warmer climate. On the other hand, in one matched case-control study gastroenteritis 
was surprisingly shown to be negatively correlated with FS.111 
Enteroviruses have been recognized as a cause of meningo-encephalitis, sometimes 
complicated by convulsions, and enterovirus can be isolated from the CSF of symptomatic 
patients.112;113 In contrast, in herpes encephalitis the virus is rarely recovered from CSF by 
culture, and one needed to obtain brain biopsy specimens for a correct diagnosis.114 
Previous studies have shown that a virus could be isolated by conventional culture 
techniques from about 50% of children with FS.115-117 Viruses that could be isolated were 
enteroviruses (coxsackievirus, echovirus), adenovirus, influenza virus, parainfluenza virus 
and RSV (see Table 1). However, the relevance of these results is disputable. The methods 
that were used showed considerable variation, and virus was seldom recovered from CSF 
(see Table 1). In the study of Wallace and Zealley only serological data were used to define 
viral illness (a fourfold or greater rise in antibody titre, with or without the isolation of the 
same virus).115 Although Lewis et al. selected 20 cases (27%) with a viral illness by isolating 
a virus from CSF, blood, or urine, the inclusion of some cases was questionable.116 From 
one of the cases two different adenoviruses were isolated. However, bacterial culture of CSF 
and blood revealed H. influenzae, suggesting that this patient in addition was suffering from 
bacterial meningitis with subsequent convulsions, rather than FS due to a viral infection of 
the CNS. On the other hand, the study of Rantala et al. shows that isolation of a virus from 
CSF provided convincing evidence of a viral infection of the CNS.117      
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Studies in the era of PCR 
With the introduction of PCR in recent years, insights into pathogenesis are changing 
because of the increased sensitivity of this method for detection of infectious agents in 
CSF.26;118-120 PCR enables the detection of infectious agents in brain tissue and in CSF that 
are otherwise hard to recover or can not be isolated at all, e.g. HSV, HHV-6 and HHV-
7.14;24;121 These developments renewed the discussion on the neurotropic capacity of viruses 
and the causal role of infectious diseases in FS. 
ES was known to be related to FS but the causative agent by then was not identified.2 
Primary infections with both HHV-6 and HHV–7 are now recognized as the causes of ES.18-
22 Although these viruses cannot be easily isolated from CSF by routine procedures, primary 
HHV-6 infections have been shown to be involved in 30% of cases of FS.23;122-126 Primary 
infection was established either by fourfold or greater rise in antibody titre in convalescent 
serum samples23;122, or by viremia in combination with seroconversion.124 In contrast, 
evidence of reactivation was defined as a second fourfold increase in the antibody titre 
and/or recurrent PCR positivity in sequential blood samples.124 
Thus, a large majority of FS cases are caused or triggered by viral infections. However, the 
question of mechanism is not yet answered; do viruses cause FS by inducing fever or do 
they have a neurotropic effect and cause viral encephalitis? Kondo et al. have reported that 
the DNA of HHV-6 was present in the CSF of patients with ES in conjunction with 
neurological symptoms (two with seizures) and suggested that an infection of the CNS by 
HHV-6 may be responsible for complex and recurrent convulsions.23 Suga et al. recently 
confirmed that convulsions after primary HHV-6 infection often show a more severe course, 
e.g. partial seizures, long lasting seizures as well as clustered seizures. In the group of 
children with subsequent epilepsy, the frequency of atypical seizures was significantly higher 
in children with primary HHV-6 infection.126 The neurotropic character of these viruses is 
furthermore supported by the demonstration of HSV, as well as the HHV-6, HHV-7 and 
HHV–8 in normal human brain tissue.127-131 In addition, several reports were published of 
cases with serious CNS manifestations that were attributed to HHV-6 and HHV-7.24;25;132-135 
Serious pathology is not only observed during primary infections with HHV-6 and/or HHV–7, 
but also after recurrent infection. Meningoencephalitis due to HHV-6 reactivation has been 
described in a stem cell transplantation patient. Both the donor and the recipient were HHV-
6 IgG positive before transplantation.136 Whether intracerebral reactivation of HHV-6 may 
result in (recurrent) FS remains to be established yet. However, Kondo et al. showed HHV-6 
DNA in CSF of patients with atypical FS 9-31 months after the onset of ES and conclude that 
HHV-6 may infect the CNS latently and may be reactivated by several factors, resulting in 
recurrent FS.23 Recent studies provide evidence that active infection by one herpesvirus can 
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mediate the reactivation of another herpesvirus, indicating that the virus which is found in 
CSF needs not to be the primary cause of the illness.137-141 
In conclusion, infectious agents seem to play an essential role in the pathogenesis of FS. 
With modern molecular techniques the presence of neurotropic viruses in CSF of children 
with FS has been proven, suggesting that these infectious agents do not cause FS merely 
through fever but can have a direct pathogenic effect at the level of the CNS. In addition, 
latency of several viruses in the CNS has been proven, as well as reactivation of these 
viruses by other actively replicating viruses. Any extracranial infection may be the trigger of 
such reactivations. The role of these pathogenic mechanisms has still to be established. 
 
RECURRENCES AND EPILEPSY AS LATE SEQUELAE OF FEBRILE SEIZURES 
 
Recurrences 
Recurrences are the most common feature of FS. Reported recurrence rates range from 
21% to 47%.4;35;45;56;142-152 There are several factors that seem to influence the risk for 
recurrent FS. First, young age at onset of fever has universally been shown to be the most 
important risk-factor.35;56;148-151;153 Second, a positive family history of FS is associated with 
an increased risk for recurrent FS.56;148;151-153 No consensus has been reached about a 
higher risk in children with a positive family history of epilepsy. Whereas some showed a 
difference between children with and without epilepsy in their families4;146;148, others were not 
able to confirm these observations.56;151-153 Furthermore, it has been suggested that complex 
or atypical FS are more often followed by recurrences.56;144;148;150 Others could not confirm 
this suggestion.4;151;152 Bias is probably the major cause of the discrepancy between these 
studies, because recurrence rates were lower in population-based studies compared to 
clinical-based series.36;144;153 Another factor that contributes to the observed discrepancy is 
the use of different definitions for complex or atypical FS. This subject still seems to be open 
for debate. Finally, the height of fever during the initial FS is inversely related to the risk for 
recurrent FS.149-151 Not all studies on recurrence risk, however, were able to confirm this 
relationship.152  
Some of the above mentioned risk factors suggest that there are groups of children with an 
increased susceptibility for febrile seizures, either supporting the theory of the existence of a 
seizure threshold or a variation in susceptibility for infections. The study of Kondo et al. 
discussed the possibility that recurrences might be related to the reactivation of specific 
viruses, especially HHV-6.23 However, Jee et al. could not demonstrate an increased risk for 
recurrent seizures in a group of 36 children with a first febrile seizure due to a primary HHV-
6 infection.154 In both studies patient groups were relatively small, too small to provide a  
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Table 2. Prognostic factors of unprovoked seizures after febrile seizures 
Study Individual Risk Factor 
Annegers et al. (1987) [11]       Complex features: 
focal 
long duration (≥ 30 min) 
repeated episodes within 24 h 
 
Verity/Golding (1991) [12] First Febrile Seizure: 
focal features 
Any Febrile Seizure: 
focal features 
long duration (>15 min) 
 
 
conclusion and further studies are needed to assess a definitive role of infectious agents in 
the pathogenesis of seizure recurrence after a primary FS. 
 
Non-febrile seizures 
Population based studies show that the rate of epilepsy after FS ranges from 1.5% to 
8%.2;10;11;155 Children with atypical FS have a higher risk of developing epilepsy than children 
with simple FS (see table 2).11;12 Moreover, it has been suggested that the risk increases 
with the number of FS, the number of complex features, and an age of less than 1 year at 
the time of the first FS.11 In addition, recurrent FS may result in partial complex seizures or 
temporal lobe epilepsy, especially when one or more complex features are present.2;11;12;71 
This might result from damage of neural tissue during seizures, finally leading to loss of 
inhibitory neurons.42;156;157 Children with a (genetic) predisposition to FS, possibly due to an 
increased susceptibility to infections, are likely to have a greater risk to develop secondary 
epilepsy. The key factor in this process may be IL-1β as we have already discussed in the 
previous paragraphs. If viral infections are involved in FS, as we suppose, then it is 
mandatory to provide evidence whether prophylactic antiviral agents may benefit these 
children or not. 
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ABSTRACT  
 
Background 
Febrile seizures (FS) are generally believed to be triggered by fever. However viral infections 
are far more frequently involved than bacterial infections, suggesting that it is not simply 
fever that causes FS. In addition, the new human herpesviruses 6 (HHV-6) and 7 (HHV-7) 
are reported to contribute to FS through invasion of the brain. Therefore, the aim was to 
study the pathogens that are involved in (complex) FS and whether these pathogens are 
present in the cerebrospinal fluid (CSF).  
Methods 
CSF, blood, a nasopharyngeal/throat swab (NT), and faeces were systematically collected 
from children admitted with complex FS. Bacterial cultures were made of blood and CSF, 
and viruses were isolated from CSF, NT, and faeces. Detection of HHV-6 or HHV-7 DNA 
was performed on CSF and blood. Paired blood samples were used for serology. 
Results 
Twenty-four children were evaluated. In 21/24 (88%) patients 29 viral infections were 
diagnosed. Infections by influenza viruses and HHV-6 or HHV-7 accounted for more than 50 
% of all viral diagnoses. No pathogens were detected in CSF.  
Conclusion 
Viral infections are of major importance in the pathogenesis of FS, in particular infections by 
HHV-6, HHV–7, and influenza viruses. However absence of these viruses in CSF indicates 
that they do not cause seizures by massive replication in the CNS. Influenza is the most 
frequent cause of FS that can be prevented by vaccination, but whether influenza 
vaccination reduces recurrent FS remains to be established. 
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INTRODUCTION 
 
Febrile seizures (FS) are the most frequently encountered neurological disorder in young 
children. In North America and Western Europe 2-5 % of all children will suffer from at least 
one FS.1-4 In the Netherlands, one quarter to one third of these children are admitted to a 
hospital because of a complex course. 
For many decades, fever has been held responsible for the occurrence of FS.5;6 However, 
most children with FS present with upper respiratory tract infections, predominantly of viral 
origin, whereas bacterial infections with comparable elevations in body temperature seldom 
cause FS. Several studies have been carried out on the role of viral infections in FS.7-9 
However these studies were performed before the discovery of two new herpesviruses, 
known as human herpesvirus type 6 (HHV-6) and type 7 (HHV-7), which cause exanthema 
subitum (ES), an exanthematous illness of childhood frequently accompanied by FS.10;11 A 
few years after the discovery of HHV-6, it was shown that infection by this virus was present 
in one third of all children with an initial FS evaluated in an emergency department.12 In 
addition, Kondo et al. demonstrated the presence of HHV-6 DNA in the CSF of ES patients 
with neurological symptoms, including FS, as well as in CSF of patients with recurrent FS 
and a history of ES.13 The authors suggested that apart from involvement of the brain in 
primary HHV-6 infection, reactivation of latent virus in the brain could be responsible for the 
recurrence of FS. In previous surveys of infections associated with FS, HHV-6 and HHV-7 
were not included because their existence was not then known. Therefore the aim of the 
current study was to determine which pathogens are involved in the occurrence of complex 
FS, including HHV-6 and HHV-7, and whether these pathogens are present in the CSF.  
 
PATIENTS AND METHODS 
 
Definitions 
An FS was defined as a seizure occurring during a febrile illness in children between the age 
of 3 months and 5 years without any other neurological conditions (e.g. intracranial infection, 
history of unprovoked seizures, or chronic anti-epileptic medication).14 Single, generalized 
FS lasting for 15 minutes or less, with full neurological recovery within 24 hours, were scored 
as simple. FS either with focal features or with recurrence within 24 hours or of long duration 
(> 15 minutes), were named complex. Multiple FS within 24 hours were considered as a 
single complex FS.  
 
 44  
 
Inclusion of patients  
Children were included in the study when they were admitted with a complex FS to one of 
the five hospitals in the province of Friesland, the Netherlands, between November 1998 and 
April 2002. A second criterion for inclusion was availability of a pair of blood samples for 
serology. A lumbar puncture was only performed at the discretion of the attending 
paediatrician. When CSF was obtained, it was in order to rule out meningitis or encephalitis. 
In addition, blood was drawn for routine bacterial culture and for polymerase chain reaction 
(PCR). Nasopharyngeal/throat (NT) swabs and faeces were collected for virus isolation. NT 
swabs were immediately placed in virus transport medium (Gelatin Lactalbumin Yeast 
medium).15 Patients were eligible for evaluation when all of the above-mentioned clinical 
specimens were available, or if only one specimen was missing. Informed consent was 
obtained from the parents or legal guardian(s) for all patients included in the study. Approval 
for the study was obtained from the local Ethics Committee in all participating hospitals. 
 
Bacteriological methods 
CSF was centrifuged at 2,000 x g for 20 minutes. The sediment was used for direct 
microscopy (Gram stain and methylene blue stain), as well as for inoculation on non-
selective and selective agar plates according to routine laboratory procedures.16 Finally the 
sediment was inoculated in a culture broth enriched with 10% horse serum (serum broth). 
Plates and serum broth tubes were incubated at 35º C in an aerobic CO2-enriched, humid 
atmosphere for a minimum of 48 hours, and were observed for bacterial growth every day. 
Serum broth was subcultured on solid media after 24 and 48 hours of incubation. These 
plates were incubated for an additional 48 hours. 
Blood was obtained for bacterial isolation in a commercial blood culture medium (BACTEC™ 
culture vials type PEDS PLUS™/F for small children; for children aged 3 years and older we 
used BACTEC™ culture vials type Plus Aerobic/F and Plus Anaerobic/F, Becton Dickinson 
and Company, Sparks, Maryland, USA). Bottles were incubated in a BACTEC™ incubator 
for a maximum of 5 days. Further analysis of positive bottles was performed according to 
standard microbiological guidelines. 
 
Virological methods 
CSF and respiratory secretions were centrifuged at 2,000 x g for 10 minutes. From faecal 
specimens about 1 gram was suspended in a mixture of 10 ml phosphate buffered saline 
(PBS) and 1 ml of chloroform.17 After vigorous shaking for 20 minutes, 5 ml of the faecal 
suspension was centrifuged (30 minutes at 2,000 x g). Equal parts of CSF supernatant, and 
200 µl of respiratory or faecal supernatant, were inoculated on 4 separate wells of 24-well 
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plates with glass cover slips containing a monolayer of either human embryonic lung cells 
(HEL), human epidermoid larynx carcinoma cells (HEp2), monkey kidney cells (LLcMK2), or 
rhabdomyosarcoma cells (RD). All 24-well plates were inspected daily for cytopathic effect 
(CPE) for a maximum of 10 days. Blind immunofluorescence (IF) staining after 1 and 10 
days was performed on all respiratory samples with monoclonal antibodies against 
respiratory syncytial virus (RSV), influenza A and B virus, and parainfluenza virus (all by 
DAKO, Glostrup, Denmark). Confirmation of CPE cultures was obtained by IF with 
monoclonal antibodies directed against suspected species.   
 
Serological methods 
Serology was performed using several different techniques. A commercial complement 
fixation assay (Serion, Clindia Diagnostics, Leusden, the Netherlands) was performed with 
the following antigens: influenza virus types A and B, parainfluenza virus types 1-3, 
adenoviruses, RSV, enteroviruses (pools 1-3), M. pneumoniae, Coxiella burnetii and a 
Chlamydia common antigen. In addition, IgM antibody was tested for influenza A virus 
(H3N2 and H1N1), influenza B virus, and for parainfluenza viruses 1-3, by a 
Haemadsorption Immunosorbent Technique (HIT).18 For cytomegalovirus (CMV), herpes 
simplex virus (HSV), varicella-zoster virus (VZV), and M. pneumoniae, in-house ELISAs for 
detection of IgM and IgA were used as previously described.19 For detection of IgG 
antibodies against CMV, HSV, and VZV, an in-house ELISA was also used.20 Antibodies 
against the Viral Capsid Antigen (IgM and IgG) and Nuclear Antigen (EBNA) of Epstein-Barr 
virus (EBV) were detected by a commercial ELISA (Serion, Clindia Diagnostics, Leusden, 
the Netherlands). For detection of Chlamydia-specific IgG antibodies, a commercial ELISA 
was used (Medac, Wedel, Germany). For detection of HHV-6 and HHV-7 specific antibodies 
an indirect immunofluorescence assay (IFA) was used. For HHV-6 IFA an in-house assay 
was developed with HSB2 cells infected with HHV-6A (strain GS) as antigen.21 For HHV-7 
IFA a commercial test was used (Bios GmbH, München, Germany). IgM detection was 
performed on twofold serial dilutions (1:10 to 1:40); IgG detection was performed on fourfold 
serial dilutions (1:20 to 1:1280). In addition, avidity of HHV-6 or HHV-7 IgG was determined 
by testing the same serial dilutions after washing the IFA-slides with an 8M-urea buffer 
instead of PBS.22 
 
Molecular methods: Detection of HHV-6 and HHV-7 DNA from CSF and blood 
DNA isolation: DNA extraction of the CSF samples and plasma was performed with the 
MagNA Pure LC and the MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche Molecular 
Diagnostics, Mannheim, Germany) according to the manufacturer’s instructions. We used a 
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starting volume of 200 µl of CSF and plasma, eluted the DNA in 50 µl, from which 10 µl was 
used for the PCR.  
HHV 6 PCR: The primers and probes (TibMolBiol, Berlin, Germany) detect a 111bp fragment 
of the HHV-6 U11 gene, a region where both variant A and B have homology.23 Therefore 
this system detects both HHV-6A and HHV-6B. LightCycler PCRs were set up in a final 
volume of 20 µl with the Fast DNA Master Hybridization Probes Kit (Roche Molecular 
Diagnostics, Mannheim, Germany), including Hotstart Taq polymerase, 4.0 mM MgCl2, each 
primer at 0.5 µM, the fluorescein labeled probe at 0.2 µM, the LC-Red640 labeled probe at 
0.4 µM, and 10 µl of the extracted DNA sample. After one step at 95°C for 10 min the 
samples were cycled 45 times (denaturation at 95°C for 5 s with a ramp rate of 20°C/s, 
annealing at 55°C for 10 s with a ramp rate of 20°C/s, and extension at 72°C for 10 s with a 
ramp rate of 20°C/s). Amplification was performed with a LightCycler Instrument (Roche 
Molecular Diagnostics, Mannheim, Germany). Fluorescence was measured once every cycle 
immediately after the 55°C incubation. Fluorescence curves were analyzed with the 
LightCycler software, version 3.5.  
HHV 7 PCR: The primers (Isogen Life Science, Maarssen, the Netherlands) amplify a 193bp 
fragment from the HHV-7 region corresponding to the HHV-6 U42 gene.24 After the first 
amplification round, 10 µl of the reaction product was used for a nested PCR. Both PCRs 
were set up in a final volume of 100 µl, including 1U Taq DNA polymerase, 75 mM Tris–HCl 
(pH 9.0), 20 mM (NH4)2SO4, 2.5 mM MgCl2, 200 µM of each deoxynucleoside triphosphate, 
5 pmol of each forward and reverse primer and 10 µl of the extracted DNA sample. An initial 
denaturation step at 94°C for 5 min was followed by 40 cycles, consisting of 1 min at 94°C, 1 
min at 50°C, and 1 min at 72°C. A final extension step at 72°C was carried out for 5 min. The 
reaction was analyzed by gel electrophoresis. 
 
RESULTS 
 
During this prospective study, 50 children were initially included. However several children 
did not return for follow-up and a second blood sample could not be obtained. These 
children had therefore to be excluded. Sufficient samples were obtained from 24 children to 
ascertain a diagnosis. A complete diagnostic set was available from 16/24 children, whereas 
in the other 8 children only one clinical sample was lacking for each child (CSF 3x, blood 
culture 4x, faeces 1x). Paired blood samples were available from all children. 
In 21/24 (88%) patients 29 separate viral infections were diagnosed. The results are 
presented in Table 1. Infections by the following viruses were diagnosed: influenza A virus 
(7), influenza B virus (1), HHV-6 (5), HHV-7 (3), RSV (5), adenoviruses (5), parainfluenza  
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Table 1. Results of microbiological tests 
Pat. CSF Blood NT## Feces Serology Causative agents 
1 - NA - - HHV-7 
Influenza A 
 
HHV-7 
Influenza A 
 
2 - - RSV NA HHV-6 RSV 
HHV-6  
 
3 - - RSV Echovirus 7 Chlamydia  RSV 
Chlamydia  
 
4 - NA - - HHV-6  HHV-6 
 
5 - NA Influenza A - Adenovirus 
Influenza A 
 
Influenza A 
Adenovirus  
 
6 - - - - -  -   
 
7 - - - Coxsackie B Coxsackie  Coxsackie B 
 
8 - - Parainfluenza virus Coxsackie A Coxsackie Parainfluenza virus 
Coxsackie A 
 
9 - - Adenovirus - - Adenovirus  
 
10 - - - - Influenza A  Influenza A  
 
11 - - - - Influenza A  Influenza A  
 
12 - - - - HHV-6  HHV-6  
 
13 - HHV-6** - - HHV-7 HHV-6 
HHV-7  
 
14 - - Influenza A 
RSV 
- HHV-7  Influenza A 
RSV 
HHV-7 
 
15 - NA - Coxsackie B Adenovirus  Adenovirus  
 
16 - - - - HHV-6  HHV-6 
 
17 - - - - -  -   
 
18 - - - Salmonella Chlamydia 
Influenza A 
 
Salmonella  
Chlamydia  
Influenza A 
 
19 - - RSV - -  RSV 
 
20 - - Influenza A - Influenza A Influenza A 
 
21 - GAS# - - -  GAS 
 
22 NA* - Adenovirus 
RSV 
- - Adenovirus 
RSV 
 
23 NA - Adenovirus Adenovirus Adenovirus  Adenovirus 
 
24 NA - - - Influenza B Influenza B  
 
*) NA = not available 
**) HHV-6 in plasma positive by PCR 
#) GAS = Group A streptococcus 
##) Nasopharynx/throat  
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virus (1), and enteroviruses (2). No micro-organisms were found in any CSF sample, either 
by conventional isolation techniques or by PCR for HHV-6 or HHV-7. 
In one third of the patients, infection with more than one virus was detected. Co-infections 
with other microbial agents were also encountered. One child with influenza was suffering 
from gastroenteritis due to concomitant Salmonella infection (patient 18). Co-infection with 
Chlamydia species was demonstrated in two patients (patients 3 and 18). A complex FS 
occurred in a child with septicaemia caused by group A streptococci (Streptococcus 
pyogenes; patient 21).  
HHV-6 infection was diagnosed in 5 children. Four children showed seroconversion in paired 
blood samples. HHV-6 DNA was detected in the plasma of one child (patient 13). The 
plasma samples of this patient revealed pre-existing HHV-6 IgG antibodies of high avidity 
without an increase of IgM and/or IgG antibody titers in the consecutive sample, indicating 
prior primary infection with HHV-6. Remarkably, this child showed seroconversion for HHV-7 
(IgM titers <10 and ≥ 40; IgG titers <20 and 80 with low avidity), suggesting HHV-6 
reactivation during primary infection with HHV-7. Two children (patients 1 and 14) showed 
primary HHV-7 infection, both in conjunction with influenza A.  
 
DISCUSSION 
 
This study confirms the major role of viral infections in the occurrence of FS. By combining 
virus isolation, serology and PCR, one or even several viral diagnoses could be established 
in 88% of our patients with complex FS. Together the influenza viruses, HHV-6 and HHV-7 
accounted for more than 50% of all viral infections.  
In 7/24 patients (29%) infections with HHV-6 and/or HHV-7 were demonstrated, agreeing 
with previous studies that reported approximately one third of initial FS as being caused by 
HHV-6 and, to a lesser extent, by HHV-7.12;25-27 It has furthermore been proposed that these 
viruses may provoke FS by invading the brain.13;28 However we were not able to detect them 
in the CSF by PCR. It is therefore debatable whether these viruses cause complex FS by 
means of a direct presence in the brain, though they may invade the CNS and cause an 
inflammatory reaction, obviously without multiplication in the CSF. HHV-6 and/or HHV-7 may 
lead to encephalitis either by primary infection29;30 or by reactivation of latent virus in the 
brain.31;32 
Influenza was diagnosed in one third of our patients. There are only a few studies that 
indicate influenza as a risk factor for FS. In a recent hospital-based study, Chiu and 
colleagues showed an association between FS and influenza A virus infections, while FS did 
not correlate with adenovirus or parainfluenza virus infections.33 In a population-based 
cohort study, conducted in parallel with the present study, we also found that influenza A 
 49  
 
was associated with FS, but mainly with recurrent FS [Van Zeijl et al. accepted J Pediatr]. 
The present study demonstrates that besides the association found in both hospital-based 
and population-based surveys, diagnostic findings in individual patients also support a 
contribution of influenza to FS. We believe that this is an important observation, since 
influenza can be prevented by vaccination. Moreover it has been proposed that recurrent FS 
may increase the risk of later unprovoked seizures.34-36 Hence it appears relevant to 
investigate whether influenza vaccination may have a beneficial effect on the recurrence of 
FS. 
 
As we have already suggested, it is somewhat unlikely that the febrile response is the major 
and independent causative factor responsible for the triggering of FS.37 Assuming, 
furthermore, that viral infections seem to be crucial in the occurrence of FS, but that the 
causative agents are not actually replicating to a large extent in the brain, other, more 
indirect pathogenic mechanisms have to be considered. Good candidates are the mediators 
of the innate immune response, the latter of which is more or less pathogen-specific and 
differs in its pattern for viruses as compared to bacteria.38 Straussberg et al. reported an 
increased lipopolysaccharide (LPS)-stimulated IL-6 and IL-10 response of peripheral blood 
mononuclear cells from children with a history of FS, compared to children without such a 
history.39 Other studies have implied that IL-1β and IL-1 receptor antagonist gene 
polymorphisms are involved in temporal lobe epilepsy and FS.40;41 Accordingly, several 
studies indicate that influenza-associated encephalopathy and FS are associated with 
enhanced systemic levels of IL-6, IL-10, TNF or soluble TNF receptor-1, as well as type 1 
interferon.42-45 Combined, these studies support a role for enhanced systemic cytokine 
responses which can mediate a pathological effect on the CNS via several direct and indirect 
pathways.37;46;47 In contrast, pro-inflammatory cytokine levels were not always found to be 
elevated in the CSF of children with (prolonged) FS.48;49 Nevertheless, it seems inevitable 
that cytokines play an important role in FS, either systemically or inside the CNS. However, 
the exact mechanism still has to be unraveled.  
 
We are aware of the fact that the inclusion of hospitalized patients may cause selection bias. 
In agreement with this point, it should be noted that in the Netherlands, children with a 
simple FS are not usually admitted to hospital50, and even when admitted, a lumbar puncture 
is seldom indicated. Admission was therefore a reflection of the severity of the illness, and 
only relatively severe cases were included. Consequently the results of our study are not 
necessarily applicable to FS in the general population. 
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In conclusion, viral infections are shown to play a major role in the development of FS, which 
holds in particular for infections caused by influenza viruses, HHV-6 and HHV-7. Although 
the exact pathogenic mechanism of FS is still not clear, an indirect, immunological pathway 
seems to be the most plausible explanation and therefore deserves more attention. It should 
be remembered, furthermore, that influenza is preventable by vaccination, but whether 
vaccination can significantly reduce the frequency of recurrent FS needs to be established. 
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ABSTRACT 
 
Objectives 
To investigate the association of viral infections and febrile seizures (FS).  
Study design 
From April 1998 to April 2002, a prospective, population-based study was carried out among 
general practitioners to assess the incidence of FS in their practices. Data thus obtained 
were compared with the incidence of common viral infections recorded in a national registry. 
Poisson regression analysis was performed to investigate whether the season or the type of 
infection was associated with the variation observed in FS incidence. 
Results 
Throughout the 4-year period, 267 of 303 (88%) of general practitioners in the Dutch 
province of Friesland participated in the study. The estimated observation period was 
approximately 160,000 patient-years. We registered 654 cases of FS in 429 children. The 
estimated incidence of FS was 2.4 in 1000 patient-years. Poisson regression analysis 
revealed a positive correlation between recurrent FS and influenza A (P = .01).  
Conclusions 
Our study suggests a relation between recurrent FS and influenza A. Influenza vaccination 
should be considered in all children with a history of FS. 
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INTRODUCTION 
 
Generally a febrile seizure (FS) is considered a harmless disorder.1 However, the condition 
leads to hospital admissions in approximately 25% of cases, tends to recur in 1 of 3 children 
with FS, and is not infrequently the forerunner of epilepsy. Moreover, a prevalence of 2% to 
5% (in North American and West European children) makes FS a major burden on an 
individual scale and for society as a whole.2-5 This, together with an as yet scarcely resolved 
pathogenesis, makes FS a relevant study subject.  
Although fever as such is commonly held responsible for the occurrence of FS, the type of 
infection appears to play a more significant role than has previously been appreciated.6 
Viruses, for instance, are far more frequently involved than bacteria, and certain viruses 
more often than others, for example, enteroviruses, adenoviruses, and human herpesvirus 
type 6 (HHV-6).7-10 A more detailed knowledge of the agents involved in FS may improve our 
understanding of FS and may possibly lead to preventive strategies. 
Incidence rates of FS show a marked seasonal variation, with peaks in the winter and at the 
end of the summer.11-14 Analysis of such seasonal trends may provide clues to the 
pathogens involved. Therefore, we prospectively investigated the incidence of FS in a cohort 
of children living in the province of Friesland, which is situated in the north of the 
Netherlands and numbers approximately 640,000 inhabitants, and compared these data with 
the incidences of common viral infections reported to a national registry. 
 
METHODS 
 
A febrile seizure was defined as a seizure during a febrile illness without other neurologic 
conditions (eg, intracranial infection, history of unprovoked seizures, or chronic anti-epileptic 
medication) occurring in children between the age of 3 months and 5 years.15 Single, 
generalized FS lasting for 15 minutes or less with full neurologic recovery within 24 hours 
were scored as simple FS. FS either with focal features or with recurrence within 24 hours or 
of long duration (> 15 minutes) were considered complex. Multiple FS within 24 hours were 
considered as one complex FS. 
From April 1998 to April 2002, all general practitioners (GPs: n = 303) in the province of 
Friesland were invited to participate in the study. FS were included by the GP, using 
standard notification cards sent every 3 months. When the diagnosis of an FS was made, 
the GP marked a “yes” box, and returned the postage paid card immediately. When a card 
with “yes” was received, one of the investigators contacted the GP by telephone for a brief 
interview and a new notification card was sent to cover the remainder of the 3-month  
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period. After 3 months, all GPs 
received a new notification card and 
were requested to return unused 
cards. The latter was done to remind 
the GPs of the ongoing study, to 
give a second chance to report 
cases, and to stimulate continuous 
participation. In addition, this policy 
enabled us to record participation in 
the study. GPs were considered to 
participate in the study if they 
returned notification cards from at 
least 8 different quarterly periods or 
if they contributed at least one case. 
Using the Dutch version of StatLine, 
the central database of Statistics 
Netherlands,16 we were able to 
calculate the size of the cohort of 
children at risk (ie, children between 
3 months and 5 years of age) as of 
January 1 of each year the study ran 
(study intervals: April to April). The 
actual sample size of the cohort was calculated by subtracting the estimated number of 
children serviced by GPs who did not participate in the study from the total cohort. 
For the calculation of incidence rates of viral infections, data were used from the weekly 
sentinel system of the Dutch Working Group on Clinical Virology (weekly reports), to which 
17 clinical virology laboratories report their laboratory-proven viral diagnoses. The registered 
diagnoses are based on virus isolation, rapid antigen tests, polymerase chain reaction, and 
serology. From the weekly reports, we used the data for infections by influenza A and B 
viruses, parainfluenza viruses, adenoviruses, respiratory syncytial virus (RSV), and 
enteroviruses. The data collected from the three Northern provinces (Friesland, Groningen, 
and Drenthe) were used. These three provinces form a homogeneous entity used by the 
Netherlands Institute of Primary Health Care (NIVEL)17,18 and by the National Influenza 
Center19 for infection surveillance. The three Northern provinces are serviced by two Public 
Health Laboratories, both of which report their virus diagnoses to the sentinel database. 
Poisson regression analysis was carried out to investigate whether the incidence of FS was 
associated with season or with the various types of viral infections and to correct for the 
Table I. Patient and seizure characteristics 
 Characteristic No. (%) 
 
No. of children with FS 
Sex difference 
Male 
Female 
Unknown 
M/F ratio  
All FS 
Simple 
Complex 
Unknown 
FS at inclusion into study  
Initial episode 
Recurrent episode 
Simple 
Complex 
Recurrences after entry to the study 
Simple 
Complex 
Unknown 
Type of initial FS (n = 388) 
Simple 
Complex 
Age at initial FS (mo) 
3-6 
6-12 
12-24 
24-36 
36-48 
48-60 
60-72 
 
429 
 
245 (57.1) 
183 (42.7) 
1 
1.3 : 1 
654 
457 (69.9) 
195 (29.8) 
    2 (0.3) 
429 
388 (90.4) 
  41 (9.6) 
302 (70.4) 
127 (29.6) 
225 
155 (68.9) 
  68 (30.2) 
    2 (0.9) 
 
276 (71.1) 
112 (28.9) 
 
    4 (1.0) 
  54 (13.9) 
193 (49.7) 
  91 (23.5) 
  22 (5.7) 
  18 (4.6) 
    6 (1.5) 
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season factor. Dependent variables evaluated were the monthly incidence of FS and its 
components and the incidence of simple and of complex FS. Explanatory variables included 
in the analysis were season (month), year, and the incidence of the various viral infections in 
that specific month as well as in the preceding months. The deviance was used to assess 
the fit of the model. When the fit was adequate and an association was found, initial and 
recurrent FS were analyzed separately. To make it easier to interpret the results, a logistic 
regression was subsequently carried out and the ratio of the risk of FS during peak periods 
in viral infections versus the risk during other periods was calculated. Any particular month 
was considered to be in a peak period if it was in the upper 25% of the monthly distribution 
of a viral infection: at least 75% of the months had a lower incidence for that specific viral 
infection. 
 
RESULTS 
 
The majority of GPs in Friesland (267 of 303; 88%) participated in the study. A total of 241 
GPs (79%) returned 8 or more notification cards. A total of 54 GPs returned fewer than 8 
cards. Among these were 26 GPs (number of cards: mean, 5.2; range, 3 to 7) who notified at 
least one case with an FS (mean, 2.4; range, 1 to 5).  
The size of the population at risk (children between 3 months and 5 years of age) was 
approximately 45,000. After correction for GP nonparticipation, the study cohort had a mean 
size of approximately 40,000 children. This corresponds to 160,000 patient-years for the 
total study period.  
During the 4-year observation period, 654 FS (388 initial events and 266 recurrences) were 
registered in a group of 429 children (Table I). The ratio of simple versus complex FS was 
7:3. There was a slight male preponderance in the occurrence of FS, which is a consistent 
finding throughout the literature.20,21 The numbers of registered FS per year (April-April) are 
shown in Table II. The estimated incidence of FS in the study period was 2.4 per 1000 
patient-years.  
Figure 1 shows the monthly distribution of all FS events from April 1998 to April 2002. A 
clear seasonal variation is observed, with pronounced peaks during the winter, nadirs during 
the summer, and small increases at the end of the summer. Figure 2 shows incidence of 
recurrent febrile seizures and incidence of influenza A and RSV for the northeastern region 
of the Netherlands during the study period. Statistical comparison of the seasonal variation 
of FS incidences with these virus incidence figures revealed a significant correlation between 
FS and influenza A (Table III). The correlation was particularly found when FS recurrences 
were taken into account. Complex FS also appears to be associated with influenza A, 
although relative risks did not always reach significance. 
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 Fig 1. Distribution of febrile seizures (all types) in 4-week intervals, from April 1998 to April 2002. 
 
 
Poisson regression analysis revealed no association between FS and RSV infections 
despite high incidence rates and a clear seasonal variation. No association was 
demonstrated with infections by influenza B virus, parainfluenza viruses, enteroviruses, or 
adenoviruses, but virus incidences were lower and a seasonal trend was less clear 
compared with those for influenza A and RSV infections. 
 
DISCUSSION 
 
With a total observation period of 160,000 patient-years, this is one of the larger population-
based studies on FS. Its findings show that the yearly peaks of FS occurring in the winter are 
substantially associated with influenza A virus activity. There was no clear association with 
any of the other respiratory viruses. For RSV infections, which show a similar seasonal 
Table II. Yearly prevalence and incidence rate of febrile seizures (April to April) 
 1998-1999 1999-2000 2000-2001 2001-2002 Mean 
 
Calculated cohort 
FS over all 
Frequency 
Prevalence rate* 
1st FS 
Frequency 
Incidence rate* 
 
44,471 
 
205 
4.61 
 
123 
2.77 
 
44,743 
 
171 
3.82 
 
96 
2.15 
 
45,608 
 
135 
3.0 
 
80 
1.75 
 
46,312 
 
143 
3.1 
 
89 
1.92 
 
45,284 
 
164 
3.62 
 
97 
2.14 
 
*Per 1000 patient-years 
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 Fig 2. Incidences of recurrent febrile seizures and incidence of Influenza A (A) and RSV (B) in 4-week  
intervals from April 1998 to April 2002. 
 
variation and higher incidence rates, compared with influenza A, there was a clear mismatch 
with the occurrence of FS. This outcome does not exclude a possible role for viruses other 
than influenza A in FS because a correlation may have remained undiscovered as the result 
of the population-based study design. The statistical technique may not have been able to  
A 
B 
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filter out and to adjust completely for the 
seasonal effects, as the seasons are 
closely associated with some of the virus 
infections (collinearity). Such inherent 
limitations can only be avoided by 
collecting diagnostic samples 
prospectively from children at the time of 
their FS. The latter was only done for a 
selected group of hospitalized children. 
In these hospitalized children the 
contribution of influenza (A and B) was 
also found to be strong, at least stronger 
than that of other respiratory viruses, 
among them RSV.22 
Influenza may be accompanied by neurologic manifestations (eg, clouding of consciousness, 
irritability, and seizures), and recent reports have reemphasized the role of influenza in 
encephalopathy, particularly in children from Asian countries.23,24 In contrast, there are only a 
few studies that indicate influenza as a risk factor for FS. Among these is a recent study 
performed in Hong Kong by Chiu et al.25 As in our study, they found an association of FS 
with influenza A virus infections but not with adenovirus or parainfluenza virus infections. 
Like other previous reports on influenza,26-31 this hospital-based study may be biased 
towards severe cases, whereas our population-based survey among GPs included all FS 
cases that came to medical attention, thereby avoiding such bias.  
Estimates of the risk of epilepsy after FS range from 1.5% to 8%,3,32-35 which is 4 to 5 times 
higher than the risk of epilepsy found in the general population (0.5% to 0.8%).3,36,37 
Consequently, it has been suggested that recurrent FS increase the risk of subsequent 
unprovoked seizures.33,35,38 Fear of this risk has led to various attempts to prevent 
recurrences of FS, but with little success.39 The clear association that we found between 
influenza and FS, in particular recurrences, implies that it is worthwhile investigating a 
possible preventive effect of influenza vaccination in children with a history of FS. 
The estimated incidence of FS in our study group was 2.4 per 1000 patient-years. This figure 
is lower than the incidence rate obtained in one other Dutch study (4.8 per 1000 patient-
years).14 It is difficult to compare the two studies, because the study carried out by Verburgh 
et al.14 was small (6195 person-years, versus 160,000 person-years in our study), of a single 
year duration, and divided into 4 periods of 3 months, each period with a different group of 
approximately 40 GPs derived from a stratified sample of Dutch GPs. A combination of these 
factors may have affected the difference in outcome of the two studies. In a prospective 
Table III. Relation between febrile seizures and  
influenza A 
  
P value* 
 
RR†
 
Total FS 
Total 
Simple 
Complex 
First episode of FS 
Total 
Simple 
Complex 
Recurrent FS 
Total 
Simple 
Complex 
 
 
.01 
.11 
.02 
 
.23 
.85 
.06 
 
.01 
.03 
.20 
 
 
1.21 
1.06 
1.54 
 
1.12 
0.94 
1.48 
 
1.35 
1.25 
1.63 
 
*Poisson regression analysis 
†Increase in risk for FS (relative risk) during influenza peaks 
(influenza rate above third quartile) compared with periods 
with low rates of influenza, after correction for season. 
 
 63  
 
incidence study of FS in Sweden (25,700 patients-years), the annual incidence was 460 in 
100,000 individuals at risk (4.6 per 1000 patient-years).21 Hauser et al.40 estimated that in 
the United States, 100,000 newly diagnosed FS are encountered annually versus 30,000 
new cases of epilepsy (recurrent unprovoked seizures) in children. From the given incidence 
of epilepsy of 50 to 100 in 100,000 one can estimate an annual incidence of FS in the United 
States of 1.7 to 3.3 per 1000 patient-years. Our findings correspond well with this estimate. 
Other studies only report cumulative incidence rates, to which our data cannot be simply 
compared.  
In conclusion, our data suggest that influenza A plays a significant role in recurrent FS in 
white children, an effect that is strong enough to be noticed at a population level. Vaccination 
against influenza may be considered after a first FS as a strategy to reduce the risk of 
recurrences. 
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ABSTRACT 
 
Background 
Influenza is associated with mild to severe neurological syndromes, but a pathogenic 
mechanism is still unknown. Influenza viruses have sometimes been detected in the brain or 
cerebrospinal fluid (CSF), which suggests virus-induced pathogenesis by neuroinvasion, but 
this was not confirmed in other studies. Alternatively, it has been proposed that influenza 
triggers reactivation of human herpesvirus 6 (HHV-6) or 7 (HHV-7) within the brain. The 
latter was reported as a potential pathogenic mechanism in Japanese children suffering from 
influenza-associated encephalopathy, but also these results could not be confirmed. No 
information exists for Caucasian children.  
Methods 
During two consecutive influenza seasons we investigated the presence of influenza virus, 
HHV-6, and HHV–7 in CSF of Caucasian children suffering from influenza-associated 
encephalopathy. 
Results 
In 9 Caucasian children, neither influenza virus RNA nor HHV-7 DNA could be detected by 
PCR, and HHV-6 DNA was detected in only 1 CSF specimen.  
Conclusions 
Our findings confirm the existence of influenza-associated encephalopathy in a non-Asian 
population. We conclude that it is unlikely that influenza virus infection causes brain 
involvement in Caucasian children by viral neuroinvasion and that reactivation of neither 
HHV-6 nor HHV–7 is involved. 
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INTRODUCTION 
 
Influenza is characterized by a broad spectrum of clinical conditions, sometimes including 
involvement of the brain. The neurological presentation, indicated as influenza-associated 
encephalopathy, ranges from irritability and drowsiness to seizures and coma.1;2 A particular 
form of influenza-associated encephalopathy, reported from Asian countries, has recently 
drawn attention because of its severity and case fatality and has been considered to be a 
separate entity.3-5 
The pathogenesis of influenza-associated encephalopathy is far from clear. Influenza viruses 
have sometimes been detected in brain or cerebrospinal fluid (CSF) samples of such cases, 
but negative results predominated. It therefore remains uncertain whether neuroinvasion by 
influenza virus does play a role.2;3;6 Alternatively it was postulated that during influenza the 
reactivation of human herpesvirus 6 (HHV-6) or 7 (HHV-7) in the brain may result in 
influenza-associated encephalopathy. These viruses are known for their neurotropic 
properties and reside latently in the brain after primary infection. This hypothesis was also 
tested but again the outcome was inconsistent: one study provided evidence for a role of 
HHV-6 and HHV-7, whereas another study did not.7;8 Because of these inconsistencies and 
also because previous studies were mainly conducted in children of Asian origin, we 
investigated the possible role of influenza virus and of HHV-6 and HHV-7 in CSF of 
Caucasian children suffering from influenza-associated encephalopathy. 
 
MATERIALS AND METHODS 
 
Cases 
Cases with influenza-associated encephalopathy were recruited at two microbiological 
laboratories (Public Health Laboratory Friesland, and University Medical Centre Nijmegen, 
the Netherlands) during two consecutive influenza seasons (2001-2002 and 2002-2003). 
Cases were only included when influenza virus had been isolated from respiratory 
specimens and a CSF sample from the acute phase of illness was available for polymerase 
chain reaction (PCR). 
 
Definitions 
Encephalopathy was defined as seizures, and/or at least 24 hours of mental or motor 
impairment (e.g. clouding of consciousness, irritability, paresis, or aphasia). Cases either on 
neurotropic medication or with intrinsic brain disease were excluded. 
 
 
 70  
 
Isolation of influenza virus: culture method 
Nasopharyngeal secretion and/or throat swabs were tested for influenza virus by a routine 
procedure on 24-well plates with glass cover slips containing a monolayer of tertiary monkey 
kidney cells or LLcMK2 cells. All 24-well plates were inspected daily for cytopathic effects for 
a maximum of 10 days. Blind immunofluorescence staining was performed with monoclonal 
antibodies against influenza A and B viruses (DAKO, Glostrup, Denmark) after 1 and 10 
days. Cultures with cytopathic effects were confirmed by immunofluorescence with the same 
monoclonal antibodies. 
 
Typing of influenza virus isolates 
All influenza virus isolates were serotyped at the Dutch reference center of the WHO in 
Rotterdam, the Netherlands.9;10 
 
Serological methods 
Serology was performed using several different techniques. A commercial complement 
fixation assay (Serion, Clindia Diagnostics, Leusden, the Netherlands) was performed with 
the following antigens: influenza viruses types A and B, parainfluenza virus types 1-3, 
adenoviruses, respiratory syncytial virus, enteroviruses (pools 1-3), M. pneumoniae, Coxiella 
burnetii and a Chlamydia common antigen. In addition, IgM antibody was tested for influenza 
A virus (H3N2 and H1N1), influenza B virus, and for parainfluenza viruses 1-3, by a 
Hemadsorption Immunosorbent Technique.11 For detection of IgM and IgA antibodies 
against herpes simplex virus, varicella-zoster virus, and M. pneumoniae, in-house ELISAs 
were used as previously described.12 For detection of IgG antibodies against herpes 
simplex- and varicella-zoster virus, in-house ELISAs were used.13 For detection of HHV-6 
specific antibodies an indirect immunofluorescence assay was used with HSB2 cells infected 
with HHV-6A (strain GS) as antigen.14 
 
Detection of influenza virus RNA from CSF  
RNA isolation: RNA was isolated from 200 µl of CSF with the High Pure RNA isolation kit 
(Roche Molecular Biochemicals, Almere, the Netherlands) according to the instructions from 
the manufacturer, with minor modifications. A 0.2-ml sample was homogenized by vortexing 
and was subsequently lysed with 0.4 ml of lysis-binding buffer containing 40 µg poly(A) 
(Roche) as a carrier. After binding to the column, DNase I digestion, and washing, the RNA 
was eluted in 50 µl of nuclease-free double-distilled water preheated to 70°C, after 
incubation at 70°C for 5 min.  
Influenza A or B PCR: amplification was essentially performed as described with the specific 
primers for either Influenza A15 or B16 with slight modifications. Briefly, 5 µl of the eluted RNA 
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was used in a 25-µl single-tube Reversed Transcriptase PCR (RT-PCR). RT-PCR conditions 
were 50 mM Tris-HCl (pH 8.5), 50 mM NaCl, 6 mM MgCl2, 2 mM dithiothreitol, 
deoxynucleoside triphosphates (1 mM each), 2.5 units of RNase inhibitor (Amersham Life 
Science, Roosendaal, the Netherlands), 6 units of avian myeloblastosis virus reverse 
transcriptase (Roche), 1 unit of Taq polymerase (Applied Biosystems, Nieuwerkerk a/d 
IJssel, the Netherlands), and 12.5 pmol of primers. Thermocycling was performed in a 
GeneAmp PCR System 9700 (Applied Biosystems) apparatus with the following cycling 
conditions: 30 min at 42°C and 4 min at 95°C once and then 1 min at 95°C, 1 min at 45°C, 3 
min at 72°C 40 times. Amplicon gel electrophoresis after ethidium bromide staining, blotting, 
hybridization with the specific biotin-labeled probe 15;16, and subsequent detection were 
conducted according to standard protocols.17  
RNA extraction, the preparation of PCR mixtures and the adding of RNA to the PCR mixtures 
were performed in a biosafety hood, equipped with UV germicidal lamps in separate, specially 
dedicated positive pressure laboratories (>10 pascal) with a lock-gate. Dedicated pipettes with 
disposable filtertips, disposable gloves and labcoats and non-reusable waste containers were 
used in these rooms. Cycling and product detection were performed in a separate laboratory on 
a different floor. 
 
Detection of HHV-6 and HHV-7 DNA from CSF  
DNA isolation: DNA extraction of the CSF samples was performed with the MagNA Pure LC 
and the MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche Molecular Diagnostics, 
Mannheim, Germany) according to the manufacturer’s instructions. We used a starting 
volume of 200 µl of CSF, eluted the DNA in 50 µl, from which 10 µl was used for the PCR.  
HHV 6 PCR: The primers and probes (TibMolBiol, Berlin, Germany) were selected in a 
111bp region of the HHV-6 U11 gene, with homology for HHV-6A and HHV-6B as to detect 
both variants.18 LightCycler PCRs were set up in a final volume of 20 µl with the Fast DNA 
Master Hybridization Probes Kit (Roche Molecular Diagnostics, Mannheim, Germany), 
including Hotstart Taq polymerase, 4.0 mM MgCl2, each primer at 0.5 µM, the fluorescein 
labeled probe at 0.2 µM, the LC-Red640 labeled probe at 0.4 µM, and 10 µl of the extracted 
DNA sample. After one step at 95°C for 10 min the samples were cycled 45 times 
(denaturation at 95°C for 5 s with a ramp rate of 20°C/s, annealing at 55°C for 10 s with a 
ramp rate of 20°C/s, and extension at 72°C for 10 s with a ramp rate of 20°C/s). Amplification 
was performed with a LightCycler Instrument (Roche Molecular Diagnostics, Mannheim 
Germany). Fluorescence was measured once every cycle immediately after the 55°C 
incubation. Fluorescence curves were analyzed with the LightCycler software, version 3.5.  
HHV 7 PCR: The primers (Isogen Life Science, Maarssen, the Netherlands) amplify a 193bp 
fragment from the HHV-7 region corresponding to the HHV-6 U42 gene.19 After the first 
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amplification round, 10 µl of the reaction product was used for a nested PCR. Both PCRs 
were set up in a final volume of 100 µl, including 1U Taq DNA polymerase, 75 mM Tris–HCl 
(pH 9.0), 20 mM (NH4)2SO4, 2.5 mM MgCl2, 200 µM of each deoxynucleoside triphosphate, 
5 pmol of each forward and reverse primer and 10 µl of the extracted DNA sample. An initial 
denaturation step at 94°C for 5 min was followed by 40 cycles, consisting of 1 min at 94°C, 1 
min at 50°C, and 1 min at 72°C. A final extension step at 72°C was carried out for 5 min. The 
reaction was analyzed by gel-electrophoresis.  
  
RESULTS 
 
Nine cases fulfilled the study requirements. Their clinical and microbiological data are 
presented in Table 1. One case is presented in more detail to illustrate the impressive 
clinical presentation, which nevertheless had a favorable outcome. 
Case presentation 
A previously healthy girl, 14 months of age, was admitted to the department of child 
neurology with a seizure lasting two hours, with fixed deviation of the head and eyes as well 
as orobuccal automatisms. The event started one day after onset of a flu-like illness 
including fever (39°C). Influenza B virus was isolated from a throat swab taken at admission. 
Further virological examination of CSF and feces was negative. Serology for respiratory and 
neurotropic agents (see Materials and Methods) remained negative. HHV-6 antibodies 
demonstrated immunity, indicating prior primary infection. MRI of the brain was normal, as 
were chemical and cytological CSF examination, serum C-reactive protein, white blood cell 
count and differentiation and metabolic screening. One day after the seizure the girl’s 
neurological signs abated and recovery was complete after one week. On follow-up 6 
months later, clinical and electro-encephalographic findings were normal. 
 
Study group 
The main characteristics of the 9 cases are presented in table 1. All cases were of 
Caucasian origin and younger than 6 years of age, and presented with fever and signs of 
brain involvement, i.e. clouding of consciousness and/or seizures. None of the cases 
showed meningeal irritation, CSF pleiocytosis, or permanent brain damage.  
Influenza A virus was isolated from nasopharyngeal secretions in 7 out of 9 cases and 
influenza B virus in 2 cases. All influenza A virus isolates were of the H3N2 type 
(A/Moscow/10/99-like) which was the predominant strain circulating in the Netherlands 
during that period.20 In only 1 out of 9 cases was HHV-6 DNA detected in CSF. None of the 
samples were positive for HHV-7 DNA. Eight out of 9 CSF samples (insufficient sample  
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volume in 1 case) were also tested by PCR for influenza A and B virus, but were negative 
(see Table 1).  
 
DISCUSSION  
 
Influenza has been described as a riddle wrapped in a mystery inside an enigma.21 The 
same would seem to be true of the ability of the virus to affect the brain. Although influenza-
associated encephalopathy has been known for decades1;2, this complication is still 
considered to occur infrequently, at least outside Asia. Our study deals with only a selected 
group of cases referred to clinics affiliated with our laboratories. Hence it does not provide 
information on the incidence of brain involvement during influenza epidemics. However 
influenza activity was low in these flu seasons (influenza-like illnesses around 10 per 10,000 
inhabitants as against 30 to 50 in the preceding 10 years). Together with other reports of 
similar cases, our experience raises some doubt as to the rarity of influenza-associated 
encephalopathy outside Asia.6;22-27 
In spite of continuous efforts, the pathogenesis of influenza-associated encephalopathy is 
still unresolved. One of the mechanisms proposed is a direct invasion of the brain through 
hematogenous spread of the virus, although viremia does not usually occur in humans.2 
Moreover the virus has only been isolated sporadically from CSF28;29, and the results of RT-
PCR on CSF samples are inconsistent.3;6;23;25;30-32 In our study, influenza virus could not be 
detected in the 8 CSF samples which we were able to test, suggesting that a direct invasion 
of the brain by influenza virus is uncommon and does not provide a solid explanation for the 
neurological complications.  
Alternatively it has been proposed that influenza may trigger the reactivation of both HHV-6 
and HHV-7, which remain latently present in the brain after primary infection. In a Japanese 
study, DNA of HHV-6 and/or HHV–7 was demonstrated in the CSF of 4/8 children with 
influenza-associated encephalopathy.7 However in a comparative group of Asian children, 
Kawada et al. could not confirm these findings and did not find any of 25 children positive for 
either HHV-6 or HHV–7 DNA.8 In our study we detected HHV-6 DNA in only 1 out of 9 
Caucasian children with influenza-associated encephalopathy, while none of these CSF 
samples contained HHV-7 DNA. Taken together, the study of Kawada et al. and our study 
support a conclusion that HHV-6 or -7 does not significantly contribute to brain 
manifestations in influenza.   
The neurological signs observed in influenza-associated encephalopathy do not seem to be 
related to viral infection of the brain, either by direct invasion or by reactivation. Recent 
studies point to a possible involvement of the innate immune response by pro-inflammatory 
cytokines, which may affect the brain by indirect means. Several studies have reported that  
 75  
 
cases suffering from influenza-associated encephalopathy or febrile seizures show 
enhanced systemic levels of IL-6, IL-10, TNF or soluble TNF receptor-1 and type 1 
interferon.30;33-35 A recent study also suggested a role for nitric oxide.36 As yet, no information 
is available on cytokine concentrations inside the brain during influenza virus infection; such 
information is eagerly awaited to shed light on the role of viral infection in encephalopathy. 
In summary, our findings confirm the existence of influenza-associated encephalopathy, 
which occurs not infrequently, also in a non-Asian population. Influenza virus was not 
detected in the CSF, nor did HHV-6 or HHV-7 seem to play a significant role. Thereby a 
pathogenic mechanism remains to be solved, but cytokines may serve as indirect mediators 
of the brain manifestations in influenza. Hence future studies should focus on a putative role 
of cytokines within the CNS as insight in these pathways may lead to new therapeutic 
interventions.  
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ABSTRACT 
 
Viral infections play an important role in febrile seizures. We present a case with three 
consecutive febrile seizures within a period of four months, with different viral etiologies for 
each febrile seizure. With each recurrence there was progression of severity of the seizures. 
This constitutes the background for a discussion on the possible consequences of recurrent 
febrile seizures.  
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INTRODUCTION 
 
Febrile seizures are relatively benign epileptiform attacks confined to early childhood. At the 
age of 6 years 2-5 % of North American and West European children have suffered from at 
least one febrile seizure, making it the most common convulsive disorder at a young age.1   
From past studies on the role of viruses in febrile seizures and from more recent studies on 
the new human herpesviruses type 6 (HHV-6) and type 7 (HHV-7), it has become clear that 
viruses are the main trigger of febrile seizures.2-5 Regarding bacteria, no correlation with 
febrile seizures has been reported, with the exception of bacterial gastroenteritis.6;7 These 
observations suggest that fever as such is not responsible for the occurrence of febrile 
seizures, but that other, as yet unidentified, factors must be involved.8  
Generally, a febrile seizure is considered quite a harmless disorder, although it tends to 
recur in one out of every three children with an initial febrile seizure, and it is not infrequently 
the forerunner of later unprovoked seizures.9 About one third of children are admitted to 
hospital because of complex features. Here we present the case history of a child who 
suffered from three consecutive febrile seizures within a period of four months, for which a 
viral etiology could be established during each event. Remarkably, with each febrile seizure 
there was progression in disease severity, causing parents and physicians to worry about 
the child’s prognosis. The putative role of recurrent febrile seizures in unprovoked seizures is 
discussed. 
 
CASE REPORT 
 
A 6-month-old previously healthy boy, who had no family history of either febrile or non-
febrile seizures, contracted his first febrile seizure in November 2001. The seizure lasted for 
approximately 15 minutes, occurred only once, and had a generalized course without focal 
symptoms. His body temperature at the time of the seizure was 38.9°C. The general 
practitioner who was called in judged the event as a simple febrile seizure and, according to 
a national guideline10, the child was not admitted to hospital. A nasopharyngeal swab 
obtained by the general practitioner for virus isolation yielded parainfluenza virus type 1. One 
month later, a complex febrile seizure occurred. Again the seizure was generalized and 
occurred once, but this time the seizure was prolonged, with a duration of 20 minutes. For 
this reason the child was admitted to hospital for further evaluation. The body temperature 
was 38.6°C at the time of the seizure. Except for symptoms compatible with the common 
cold, physical examination revealed no abnormalities. No invasive tests were performed, and 
after a night of observation the child was discharged. A nasopharyngeal swab, obtained 
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before admission, now yielded respiratory syncytial virus type B (RSV-B) (RSV subtyping: 
Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands).11 
A new generalized complex febrile seizure occurred in February 2002, which now continued 
for almost one hour despite repeated rectal application of diazepam, and again the child was 
admitted. We saw an unconscious boy with a rectal temperature of 39.7°C, generalized 
hypertonia and focal jerks of the right arm. After intravenous injection of diazepam the 
seizure finally came to an end. Peripheral blood indices including hemoglobin, C-reactive 
protein, white blood cell count, and white blood cell differentiation were normal. Blood 
glucose concentration was elevated (13.8 mmol/l; reference value <8.0 mmol/l). A lumbar 
puncture was performed, and CSF showed normal white blood count, glucose 4.7 mmol/l 
(range 2.2-3.9 mmol/l), and protein 0.45 g/l (age-adjusted range 0.15-0.30 g/l). Bacterial 
culture of CSF and blood yielded no growth. This time, RSV type A was isolated from the 
nasopharynx. Polymerase chain reaction (PCR) on CSF for HHV-6, HHV-7, as well as 
reverse transcriptase (RT)-PCR for RSV and human metapneumovirus, were negative. 
Extensive serology for respiratory as well as other viruses (including HHV-6 and HHV–7), 
performed on paired serum samples, failed to reveal any infection by other pathogens.  
The child recovered quickly and was discharged the other day. Twenty-four months of 
follow-up revealed that the boy contracted at least ten additional febrile seizures, and  
eventually showed progression toward unprovoked seizures, despite prophylactic medication 
with valproic acid, initiated after the fourth febrile seizure.  
 
DISCUSSION 
 
This case history illustrates the importance of viral infections in febrile seizures. Most 
children with febrile seizures show signs of upper respiratory tract infections, predominantly 
caused by common respiratory viruses, which is also supported by the seasonal variation of 
febrile seizure incidence, with peaks during the respiratory season in the winter period [Van 
Zeijl et al. accepted J Pediatr].12-14 
Our case suffered from RSV infection twice, as well as from parainfluenza virus infection. 
Infections by these viruses have been reported in cases with febrile seizures, but they have 
not particularly been indicated as a risk factor for febrile seizures.3;4;15;16 
In this case, each recurrence was accompanied by a progression in severity of illness. 
Duration of the seizures increased over time, changing the character of the febrile seizure 
from a simple to a complex type. Moreover, the second recurrence was refractory to anti-
convulsive medication, whereas the first two seizures ended spontaneously. Recurrences 
occur in about one third of all children with febrile seizures, and are associated with an 
increased risk for subsequent unprovoked seizures.9 Of children with a history of febrile 
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seizures, 1.5–8 % develop epilepsy, which is a four- to five-fold increase compared to the 
general population. Other risk factors for later occurrence of unprovoked seizures are a first 
febrile seizure with focal symptoms and a family history of epilepsy. The relationship 
between febrile seizures and subsequent epilepsy is not clear. Animal studies have shown 
that febrile seizures may reduce the threshold for subsequent unprovoked seizures, 
suggesting that the febrile response has a causative role and should be prevented.17 
Unfortunately, prevention of recurrences by antipyretic medication proved to be 
unsuccessful.18 Alternatively, recurrence of febrile seizures may reflect an intrinsic 
susceptibility to develop epilepsy, the manifestation of which is only initially triggered by 
infections. However an approach of long-term prophylaxis with anti-epileptic medication is 
not believed to outweigh the adverse effects of such a treatment.  
This brings us to a third possibility, i.e. the prevention of infections that are particularly 
involved in febrile seizures. The risk of recurrence as a feature of specific viral infections has 
been examined only briefly. Kondo et al. suggested that HHV-6 infection of the CNS may be 
associated with recurrence of febrile seizures.19 However, this observation has so far not 
been confirmed by other recent studies. We made a second and more promising 
observation. In a population-based study, we were able to demonstrate an association of 
recurrent febrile seizures with influenza A [Van Zeijl et al. accepted J Pediatr]. Further 
studies are needed to establish whether active prevention of specific infections will lead to a 
decrease of recurrent febrile seizures, and of later unprovoked seizures.  
 
In summary, a case is presented which illustrates the relationship of febrile seizures with the 
subsequent development of unprovoked seizures. Such an outcome means that febrile 
seizures should be considered with some suspicion, being not so benign as generally 
accepted. In the long term, recurrences may be responsible for unprovoked seizures. So far 
the pathogenesis of febrile seizures and their relationship with subsequent epilepsy is poorly 
understood. These aspects warrant more scientific attention because here may reside a 
solution for prevention of epilepsy.  
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ABSTRACT 
 
Although febrile seizures (FS) generally follow a benign course, recurrences are observed in 
about one third of all children with a first FS. In addition, recurrences are associated with an 
increased risk for subsequent unprovoked seizures. We investigated the contribution of 
several characteristics of FS to recurrence risk in Dutch children who were included in a 
prospective population-based cohort study on the incidence of FS. 
This study was confined to cases with a first FS as from April 1998, and a 2-year follow-up 
completed by December 2002. Follow-up consisted of a three-monthly paper questionnaire 
sent to the general practitioner of each included child, including questions on recurrences, 
pediatric consultation, and complications related to the initial FS. For recurrences, a 
telephone questionnaire was taken for demographics (age, sex), seizure characteristics, co-
morbidity, as well as management (hospital admission and medication). Cox proportional 
hazards analysis was performed to assess the relationship between the various parameters 
and either the risk of at least one recurrence or the risk of a second recurrence.  
Recurrences were observed in 92/263 included cases (35%). From these cases, one third 
experienced a second recurrence. Both initial and recurrent FS were correlated with age, the 
majority of them occurring before the age of 24 months. Most recurrences occurred within 6 
months after the initial FS. A positive family history of FS and/or epilepsy was correlated with 
a first recurrence, while an initial complex FS was correlated with a second recurrence. A 
short seizure-free interval between the initial FS and first recurrence is also correlated with 
later recurrences. 
We conclude that the results from this study are in agreement with results from previous 
studies, indicating the representative nature of the cohort studied. 
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INTRODUCTION 
 
The occurrence of a febrile seizure (FS) in a child is a frightening experience for parents and 
other carers. Although they may be reassured by the excellent prognosis of most FS, they 
will fear recurrent episodes for several years. According to the literature about one third of all 
children with a first FS will experience one or more recurrences.1;2 Approximately 50% of all 
recurrences occur within 6 months after the first FS, 75% within a year, and 90% within 2 
years.3 Similar to the initial FS, subsequent recurrences are typically age-dependent.3-5 This 
age-dependent incidence probably reflects a developmental niche of the brain with a 
temporary increase of susceptibility to epileptiform excitation.5 A moderate elevation of 
temperature at the time of the initial FS, as well as a family history for FS in first degree 
relatives, are other risk factors for recurrent FS consistently reported in the literature.3;5-9  
In the present study we investigated the contribution of FS characteristics to recurrence risk 
in Dutch children who were included in a prospective population-based cohort study on the 
incidence of FS.  
 
MATERIALS AND METHODS 
 
Study group 
This study is part of a population-based prospective cohort study on FS, conducted in the 
province of Friesland, the Netherlands, described in detail in Chapter 4. This part of the 
study is confined to cases entering the study with a first FS as from April 1st 1998, with a 2-
year follow-up completed by December 1st 2002. 
 
Definitions 
An FS was defined as a seizure during a febrile illness without other neurological conditions 
(e.g. intracranial infection, history of unprovoked seizures, or chronic anti-epileptic 
medication), occurring in children between the age of 3 months and 5 years.10 A single, 
generalized FS lasting for 15 minutes or less, with full neurological recovery within 24 hours, 
was scored as simple. An FS either with focal features, or with recurrence within 24 hours, or 
of long duration (>15 minutes), was qualified as complex. Multiple FS within 24 hours were 
considered as one complex FS. 
 
Inclusion of cases 
Each general practitioner (GP: n=303) in the study region was requested to report cases 
fulfilling the above definitions. Notification was by means of a three-monthly standard form. 
Each notification was checked by one of the investigators (JZ) using a standard telephone 
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questionnaire. The questionnaire included demographics (sex, age), seizure characteristics 
(frequency, presentation and course), co-morbidity (skin rash, meningitis, unprovoked 
seizures and neurological sequels), family history for FS and/or epilepsy, and management 
including hospital admission and anti-epileptic medication. 
All cases entering the study underwent a 2-year follow-up using a three-monthly standard 
paper questionnaire sent to the GP, which included questions about recurrences (yes or no), 
pediatric consultation (if “yes”, for what reason), and events or complications related to the 
initial FS. When a recurrence was reported, a questionnaire similar to the one used for initial 
FS was taken by telephone. 
 
Statistics 
The relationship between the various parameters and the risk of recurrence was evaluated 
using Cox proportional hazards analysis for both the risk of at least one recurrence and the 
risk of a second recurrence. Cases were divided into three age groups (≤ 12 months, 13-30 
months, and > 30 months). Age intervals were chosen in order to enable comparison with 
data from another Dutch study.5 Both univariate and multivariate analyses were carried out. 
For the multivariate analysis the criterion for including or retaining the variables was set at 
p<0.10. Two-sided 95% confidence intervals and p-values were calculated. 
 
RESULTS 
 
Eighty-eight percent (n=267) of all GPs participated in the main study (see Chapter 4). From 
the 429 cases that were reported, a total of 301 were enrolled in the follow-up study. Thirty-
eight cases were excluded because they entered the study with a recurrent FS. This follow-
up study is therefore based on 263 cases that fulfilled the requirements of this part of the 
study, i.e. intake with a first FS, and a complete two-year follow-up on the pre-determined 
end date. In three cases follow-up was ended prematurely because of the development of 
unprovoked seizures. No cases were lost to follow-up. 
Main demographic and clinical characteristics of the included cases are listed in Table 1. FS 
are slightly more common in boys, and are characterized by their occurrence in early 
childhood (median age 18 months), with a rapid decline after the age of 3 years. Information 
on the family history was available for 235 cases. Seventy-two (31%) of these cases had a 
first-degree relative with FS and/or epilepsy (these variables were not scored separately). 
One third of all initial FS followed a complex course, and four out of every ten cases were 
admitted to hospital for their first FS. In line with a national protocol, which states that cases 
with complex FS should be admitted11, 78% of the cases with a complex course were indeed 
admitted to hospital, versus 21% of the cases with a simple FS. In our study, we were  
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Table 1: Patient and seizure characteristics at entrance into the study (n=263) 
Patient characteristics N (%) 
Sex   
Female 119 (45) 
Male 143 (55) 
Unknown 1  
   
Age at onset (months)   
    ≤ 12 51 (20) 
13 – 24 122 (46) 
25 – 36 62 (24) 
37 – 48 14 (5) 
49 – 60 11 (4) 
61 – 72 3 (1) 
   
Family history of seizures (febrile and/or unprovoked)   
No 163 (69) 
Yes 72 (31) 
   
Seizure characteristics   
Type of seizure   
Simple 171 (65) 
Complex 92 (35) 
Prolonged (>15 min) 47 (18) 
Multiple (>1 per 24h) 45 (17) 
Focal 26 (10) 
   
Hospital admission   
No 155 (59) 
Yes 
 
108 (41) 
 
unable to analyze the contribution of both the peak temperature and duration of fever at the 
first FS because these two parameters were not registered by GPs or parents in a sufficient 
number of cases. 
In 92 (35%) of the 263 observed cases one or more recurrences occurred. Thirty-three 
cases (13%) had two or more recurrences, while 16 cases (6%) suffered from at least 3 
recurrences within the follow-up period. One third (33/92) of cases with at least one 
recurrence also had a second recurrence, while 16/33 (48%) of those with two recurrences 
contracted a third (p=0.20). Most recurrences (61%) occurred in the first 6 months after the 
initial FS.  
Compared to cases without recurrences, those who had recurrent FS contracted their initial 
FS at a younger age. In cases with at least one recurrence the median age at the initial FS 
was 17 months, compared to 20 months in those without recurrences. In cases with two or 
more recurrences the median age was 15 months.  
Table 2 presents the results from the Cox proportional hazards analysis either for the risk of 
at least one recurrence or for the risk of a second recurrence. The table lists the risk factors  
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that were examined, the number of registered cases with each risk factor, as well as the 
hazard rate ratios (with 95% confidence intervals).  
In the univariate analysis the risk of at least one recurrence was significantly correlated with 
a family history of FS and/or epilepsy. This variable was also significantly correlated with 
recurrence risk in a multivariate approach (p=0.02). As family history had many missing 
values, an additional analysis was done, excluding family history. In this case only age > 30 
months was selected (p<0.10), which correlates with a 41% lower recurrence risk (hazard 
rate) compared with the reference group (13-30 months of age). Young age (≤ 12 months) 
was not significantly correlated with recurrence risk, when compared with the reference 
group. Other variables were not significantly correlated with an increased risk for at least one 
recurrence. 
The risk of a second recurrence was significantly correlated with a complex course of the 
initial FS (Table 2). No significant correlation was found between the risk of a second 
recurrence and any separate complex feature. The chance of a second recurrence was also 
significantly increased when the first recurrence followed shortly upon the initial FS. With 
each 1-month increase in the interval between first occurrence and first recurrence, the risk 
of a second recurrence (hazard rate) decreases by approximately 9% (this corresponds to 
68% per year).  
 
DISCUSSION 
 
The most frequent outcome that follows an initial FS is the recurrence of FS. In our study 
one third of all cases suffered from at least one recurrence, while two and three recurrences 
occurred in 13 and 6% respectively. These recurrence frequencies are similar to those 
reported in most other studies on this topic.5;8;12 With respect to the recurrence of FS four 
definite risk factors can be identified from the literature. These are young age at the initial 
FS, a family history of FS, as well as peak temperature and duration of fever.8;9 For several 
other (risk) factors there is less agreement about their association with recurrences. In this 
preliminary follow-up study, which was accomplished for a part of the cohort, we analyzed 
 
Age at first FS 
For the sake of comparison of data within the Netherlands, we deliberately chose the same 
age intervals as used in the study by Offringa et al.5 Accordingly young age (≤ 12 months) 
was not significantly associated with an increased recurrence risk in the present study. This 
result is in contrast to most previous studies.12 However there is considerable variation in 
age cutoff points among studies, ranging from 12 to 18 months, which may have been 
responsible for the observed differences in outcome. In support of an effect of age, we found  
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a lower recurrence risk when the initial seizure occurred above the age of 30 months, which 
was also reported by Offringa et al.5  
In children with recurrences we observed an increase in recurrence susceptibility from the 
very young to those aged between 13-24 months, and a rapid decline of recurrence risk 
thereafter, which is similar to the age-related increase and decrease of first FS (see Table 
1). This typical pattern has been described previously and may reflect a critical period of 
seizure vulnerability, which can be explained by two independent events: on the one hand a 
temporary susceptibility, inherent to immaturity of the brain, that subsides with age13;14 and, 
on the other, an increased susceptibility to infections because of waning protection by 
maternal antibodies, followed by acquisition of immunity against repeating infections. 
 
Family history of febrile and unprovoked seizures 
In our study a positive family history of FS and/or epilepsy was significantly associated with 
an increased risk of at least one recurrent FS. We had to combine both variables into one 
risk factor because too often GPs were only able to recall a history of seizures, and could not 
specify a history of either FS or epilepsy. However, only a history of FS in first-degree 
relatives has been universally found as a risk factor of at least one recurrence. A family 
history of epilepsy is less consistently associated with the risk of one recurrence.3 In 
contrast, a family history of epilepsy is correlated with subsequent unprovoked seizures and 
epilepsy, whereas a family history of FS is not.15-17 The paradoxical relation of these two 
variables has previously been observed.17 It has been suggested that FS and epilepsy are 
quite distinct syndromes in origin, whereas children with both recurrent FS and subsequent 
unprovoked seizures may constitute a risk group with an underlying, probably inherited, 
seizure susceptibility. 
 
Fever at onset of the initial FS 
Although we were unable to generate sufficient data on this topic, it is known from previous 
studies that the risk of a first FS is strongly associated with a high degree of fever, whereas 
recurrence risk increases with a lower temperature at onset of the first FS.6;18 This finding 
suggests that children who present with seizures in response to moderate fever have a lower 
seizure threshold and are readily prone to additional seizures following subsequent episodes 
with fever.  
 
Type of first FS 
We were able to demonstrate a significant association between a complex course of the 
initial FS and the risk of a second recurrence in both univariate and multivariate approach. 
However, the literature on the predictive value of complex features on recurrence risk is 
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rather inconsistent. It is difficult to compare the various studies on prediction of recurrences 
because some are hospital-based, while others follow a population-based strategy. In the 
hospital-based surveys the cases included probably had a more severe presentation, 
necessitating observation in hospital. Risk factors leading to hospital admission will therefore 
be over-represented in these studies. Obviously, risk factors which always lead to 
admission, e.g. complex features, will not be identified as such because cases both with and 
without recurrences demonstrate the same variable. This may explain why only population-
based studies have found complex features (or complex type) to be risk factors for 
recurrences.3 We believe that complex features are prognostic for second and further 
recurrences, also because complex FS are associated with an increased risk of subsequent 
unprovoked seizures.16;17;19  
 
Time between initial FS and 1st recurrence 
In our study we found that a short seizure-free interval between the initial FS and a first 
recurrence was significantly correlated with the risk of a second recurrence. It has been 
suggested by others, however, that subsequent recurrences (i.e. two or more recurrent FS) 
rather reflect the occurrence of both initial and recurrent FS during a particular period of 
increased seizure susceptibility during the second year of life.5;7;8 This means that age at 
both initial and recurrent FS is probably a more important issue than the duration of the 
seizure-free interval itself. Indeed, children with recurrences tend to experience their first FS 
at a younger age than those without recurrences, while children with more than one 
recurrence had an even younger median age at initial FS. 
 
In conclusion, occurrence as well as recurrence of FS is typically age-dependent. A positive 
family history of FS and/or epilepsy is found to be a significant risk factor for at least one 
recurrence, while one or more complex features of the initial FS is significantly correlated 
with a second recurrence. A short seizure-free interval between initial FS and first recurrence 
is also correlated with later recurrences. On the whole these findings are in agreement with 
results from previous studies, and the fact that no unexpected findings were obtained leads 
us to conclude that the cohort, which we followed for several years, is representative with 
respect to additional studies on FS, as presented in this thesis.  
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THE PATHOGENESIS OF FEBRILE SEIZURES  
 
Febrile seizures are considered to be benign convulsive events in young children without 
evidence of intracranial infection or other neurological conditions (i.e. history of unprovoked 
seizures or chronic antiepileptic medication). However recurrences are observed in one third 
of all children who experience a first febrile seizure, and children with febrile seizures are at 
increased risk of presenting with subsequent unprovoked seizures, especially those children 
with recurrent febrile seizures.1-3 The pathogenesis of this relationship is poorly understood. 
Various attempts have been made to prevent recurrences with either antipyretic or 
antiepileptic medication, but with little success, offering no prospect of improvement in the 
prognosis for these patients.  
Although fever is a sine qua non in diagnosing febrile seizures, it is unlikely that it is the 
single causative factor. Febrile seizures occur predominantly during viral infections, 
suggesting specific involvement of these agents in the pathogenesis, either directly or 
indirectly. The discovery of the new human herpesviruses types 6 (HHV-6) and 7 (HHV-7), 
which are neurotropic and frequently associated with febrile seizures, has renewed the 
discussion on the role of infections of the brain. Are these and other agents able to induce 
febrile seizures either by invasion of or reactivation within the central nervous system 
(CNS)? To address this question we undertook the investigations described in this thesis, 
with special emphasis on the contribution of viral infections and their presence in the 
cerebrospinal fluid (CSF).  
 
In Chapter 1 we detail our study aims and present a short outline of this thesis. The aims 
were to assess (1) the spectrum of infectious agents that contribute to febrile seizures; (2) 
whether these pathogens invade the brain; (3) the possibility of reactivation of HHV-6 and 
HHV-7 in the brain; and (4) the contribution of specific infections to recurrent febrile seizures. 
Chapter 2 presents a review of the literature on the determinants of the pathogenesis of 
febrile seizures, with special focus on the type of infection involved, because we expected 
that the latter might provide insight into the underlying mechanism(s). The main 
determinants were: (1) an age-dependent occurrence suggesting a temporary decrease in 
seizure threshold during early childhood, restoring with maturation of the brain; (2) a genetic 
predisposition, not clearly linked to HLA, suggesting that special susceptibility to some kinds 
of infection is an unlikely explanation; (3) an intriguing but unexplained relationship with the 
eventual development of unprovoked seizures, which at least holds for a subpopulation of 
children. The latter suggests that febrile seizures are either not innocent and may result in 
later epilepsy, or that an intrinsic susceptibility towards unprovoked seizures initially 
manifests as a provoked seizure. Finally, as fourth determinant, it was found that viral 
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infections are the main triggers of febrile seizures, in contrast to their bacterial counterparts. 
This observation, which is the main subject of the thesis, suggests either that viruses may 
affect the brain directly or that they provoke a host response that clearly differs from that 
caused by bacteria and other microbial pathogens, and which brings about an 
encephalopathic reaction within the brain. It is concluded that, as well as there being a 
genetic predisposition, a specific role can be ascribed to viruses, which may uncover 
important features in the pathogenesis of febrile seizures. As a future perspective, 
prophylactic antiviral treatment may prevent or reduce long-term sequelae of febrile 
seizures. 
 
FEBRILE SEIZURES AND INFECTIONS 
 
In Chapter 3, the results are described of a hospital-based study performed in the Dutch 
province of Friesland. The study was initiated to investigate which pathogens are particularly 
involved in febrile seizures and whether these are detectable in the CSF as an indication of 
neuroinvasion. Special attention was given to a possible role of HHV-6 and HHV-7 infection. 
Eligible were children for whom a full set of diagnostic samples was available. These 
children were hospitalized with complex features of the febrile seizure and suspicion of either 
meningitis or meningoencephalitis, thus cases with a rather serious presentation. All children 
were of Caucasian origin. 
The study confirms that viruses play a major role. One third of the patients were suffering 
from influenza. An additional one third showed infections caused by HHV-6 and/or HHV-7, 
some of them also being concomitantly infected with influenza virus. Infections by influenza 
viruses, HHV-6, and HHV-7 combined accounted for more than 50% of all viral diagnoses. 
Remarkably, no pathogens were detected in the CSF, neither by culture nor by PCR (HHV-6 
and HHV–7).  
We conclude that viruses are the main triggers of febrile seizures, although direct viral 
invasion and infection of the brain plays only a minor role – if any at all – in (complex) febrile 
seizures. Therefore we speculated that an indirect, immunological pathway will be the most 
plausible explanation for the pathogenesis of febrile seizures. As discussed in this chapter, 
as well as in chapters 4 and 5, there is growing support for this view from studies on both 
febrile seizures and influenza-associated encephalopathy. 
 
Chapter 4 presents the results of a prospective population-based cohort study, conducted in 
general practices in the province of Friesland. This study was initiated in order to acquire 
baseline characteristics of febrile seizures in the population from which the hospitalized 
children were selected, as well as to investigate involvement of viruses on a population level. 
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The latter was done by comparing incidences of febrile seizures with those of common viral 
infections recorded in the weekly sentinel system of the Dutch Working Group on Clinical 
Virology. Data were taken for the three northern provinces, which form a homogeneous 
entity in viral surveillance networks such as the National Surveillance for Influenza. 
Moreover, virus infection diagnostics for these three provinces is centralized in two Regional 
Public Health Laboratories in Leeuwarden and Groningen, which more or less guaranteed 
an equal diagnostic standard. 
During the 4-year study period, 267/303 (88%) general practitioners participated in the study, 
resulting in an estimated observation period of approximately 160,000 patient years, which 
makes this study one of the largest population-based studies ever conducted on febrile 
seizures. Patient characteristics as well as characteristics of the seizures were similar to 
those of previous studies, such as a slight male preponderance (male : female = 1.3 : 1), 
and a ratio of simple versus complex febrile seizures of 7 : 3. Fifty percent of all included 
children experienced their first febrile seizure during the second year of life.  
The mean annual incidence of febrile seizures in this cohort was 2.4 per 1,000 patient years, 
which is concordant with literature from other countries, but lower than has been reported in 
another Dutch study.4 Underreporting during our study was considered an unlikely 
explanation, but geographical differences, as well as the different size of the two studies, 
may have been responsible for the observed difference.  
A clear seasonal variation was observed in the incidence of febrile seizures. Statistical 
analysis yielded a significant association between febrile seizures and influenza A, 
particularly when recurrences were taken into account. The relationship between febrile 
seizures and influenza A is in agreement with the results described in chapter 3, but also 
with a recent hospital-based study from Hong Kong.5 This is an important observation, 
because influenza can be prevented by vaccination and thereby possibly also its later 
sequelae. Further studies are needed to demonstrate whether influenza vaccination can 
significantly reduce the number of recurrent febrile seizures, and maybe also that of 
subsequent unprovoked seizures. 
There was no clear association with one of the other respiratory viruses reported to the 
registry. This may be partly due to the relatively insensitive approach, in which a low 
incidence in the registry, and/or a weak seasonal variation, may have masked a role of other 
viruses. This does not hold for RSV infections, which showed not only the highest incidence 
but also the sharpest seasonal trend of all respiratory infections. In spite of this, an 
association with febrile seizures was not found. In contrast with this notion, in chapter 6 we 
describe a case with two recurrent seizures in the course of RSV infections, illustrating that 
RSV may cause febrile seizures, though apparently not so frequently as to uncover its 
contribution by the approach applied in this study. Prospective studies, as reported in 
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chapter 6, are needed to demonstrate the contribution of other respiratory and common 
viruses.  
Once again this study illustrates the significant role of influenza which, in spite of the low 
seasonal activity of the last several years, was revealed by the approach that was followed.  
 
INFLUENZA-ASSOCIATED ENCEPHALOPATHY 
 
The significant role of influenza, which was not foreseen when the study was initiated, 
particularly drew our attention. In the meantime, several reports had described a serious 
form of influenza-associated encephalopathy in children from Asian countries. Moreover, it 
was reported that reactivation of HHV-6 or HHV–7 may be involved in the pathogenesis of 
this syndrome, although this could not be confirmed in a second study.6;7 In order to 
investigate this possible pathogenic mechanism we therefore started to collect CSF samples 
from children showing signs of encephalopathy and from whose throat the influenza virus 
had been isolated, which indicates the acute phase of influenza. Chapter 5 describes this 
study in which we investigated the possible role of influenza virus and of HHV-6 and HHV-7 
in 9 Caucasian children diagnosed with influenza-associated encephalopathy. Neither 
influenza virus RNA nor HHV-7 DNA could be detected by PCR, and HHV-6 DNA was 
detected in only 1 CSF specimen. From this study we conclude that it is unlikely that 
influenza virus caused brain involvement in these Caucasian children by neuroinvasion or 
that reactivation of HHV-6 or HHV–7 is involved. Moreover, the study shows that influenza-
associated encephalopathy does not occur only in Asian children but also in Caucasians, 
although the severity may vary between these ethnic groups. Our study does not provide 
information on the incidence of brain involvement during influenza epidemics. The samples 
were collected in the Public Health Laboratory of Friesland and the Department of Medical 
Microbiology of the University Medical Centre Nijmegen during two influenza seasons. 
During these seasons, influenza activity was low, suggesting that the significance of brain 
involvement during influenza is underappreciated.  
 
RECURRENCE OF FEBRILE SEIZURES 
 
When a child experiences a febrile seizure, parents usually show major concern about the 
prognosis, especially regarding recurrences and subsequent epilepsy. Febrile seizures tend 
to recur in 30-40% of children with a febrile seizure. About half of all recurrences occur within 
the first 6 months after the initial seizure. As already mentioned, recurrences are associated 
with an increased risk of subsequent unprovoked seizures.  
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In Chapter 6 we present a child that suffered from 3 consecutive febrile seizures within a 
period of 4 months. For each episode a viral etiology could be established. The first febrile 
seizure occurred in the course of an infection with parainfluenza virus. RSV infection was 
demonstrated twice, during subsequent recurrences. Each recurrence was accompanied by 
progression in severity of symptoms. Follow-up revealed a series of additional recurrences, 
and eventually the child developed unprovoked seizures despite prophylactic medication, 
initiated after the fourth febrile seizure. 
Recurrence risk as a feature of viral infections has been examined only briefly. RSV and 
parainfluenza virus infections have never been related to recurrent febrile seizures. In 
contrast, we found an association of influenza A with recurrent febrile seizures (see chapter 
4) and it has been previously suggested that recurrences may be caused by reactivation of 
HHV-6 in the CNS.8 Although a causal mechanism has yet to be elucidated, we consider 
that several viral infections not only contribute to the occurrence of initial febrile seizures, but 
also to recurrences. Therefore interventions would do better to focus on the prevention of 
these viral infections rather than on the current, more symptomatic approach.  
 
Several studies have been performed to analyze risk factors that contribute to the recurrence 
of febrile seizures. From these studies it was generally concluded that young age, a positive 
family history of febrile seizures, as well as peak temperature and duration of fever, were 
consistent risk factors for the recurrence of febrile seizures. For other presumed risk factors, 
e.g. sex and type of seizure, less agreement has been reached. Chapter 7 presents the 
preliminary results of a follow-up study on risk factors of recurrent febrile seizures in a part of 
our cohort. Recurrences were observed in 92/263 included cases (35%). From these cases, 
again one third experienced a second recurrence.  
Our study confirms that both initial and recurrent febrile seizures are strongly correlated with 
age, a majority of them occurring before the age of 24 months. Most recurrences (61%) 
occurred within 6 months after the initial febrile seizure. Similar to the age distribution in 
children with initial febrile seizures, we observed a temporary increase of recurrent febrile 
seizures from the very young to those aged between 13 and 24 months, with a rapid decline 
of the recurrence risk thereafter. This may reflect a developmental niche of the child’s brain, 
caused by an increased susceptibility to epileptiform excitation subsequently subsiding with 
age.9;10 On the other hand, we suggest that this age-dependent pattern in recurrence risk 
may at least partly be caused by a temporary increase of susceptibility to infections.  
A positive family history of febrile seizures and/or epilepsy in first-degree relatives was 
significantly associated with a first recurrence. Unfortunately the study approach prevented 
an analysis of these separate variables. However previous studies consistently demonstrate 
a history of febrile seizures only as a risk factor of first recurrence, whereas a history of 
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epilepsy may increase the risk of both febrile and unprovoked seizures. This suggests a 
difference in pathogenesis between febrile seizures and unprovoked seizures.  
Complex features of the initial FS were associated with an increased risk of a second 
recurrence. This is a controversial finding, as other studies have produced inconsistent 
results. However we suggest that a population-based format is required to find such a 
correlation.11  
Finally, a significant correlation was observed between a short seizure-free interval (i.e. the 
time between the initial febrile seizure and the first recurrence) and the risk of a second 
recurrence. However this again may reflect the age-dependent occurrence of both initial and 
recurrent febrile seizures, as mentioned before.  
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RÉSUMÉ AND FUTURE PERSPECTIVES  
 
We conclude that viral infections are the main cause of febrile seizures, with an important 
role for influenza A, HHV-6 and HHV-7. We showed that several viral infections not only 
contribute to initial febrile seizures, but also to recurrences. Viruses could not be detected in 
the CSF of children with febrile seizures, suggesting that neither neuroinvasion, nor 
reactivation within the brain, are important causal mechanisms of disease. Our findings 
implicate that fever as such is not responsible for the occurrence of febrile seizures, as is 
also demonstrated by the fact that antipyretics are unable to prevent recurrences on the long 
term. Other, more indirect underlying conditions must be involved and we consider cytokines 
to act as indirect mediators of febrile seizures.  
Recurrences are associated with subsequent unprovoked seizures and it has been 
suggested that the association is causal, i.e. that recurrences increase the risk of epilepsy. 
However, it may be the other way round and little is known about the relationship, let alone 
any underlying mechanism. Such insight is of major importance since it may offer new ways 
to prevent epilepsy. The correlation between influenza A and recurrent febrile seizures, 
which we found in this study, offers a possibility to investigate the relationship by indirect 
means, because influenza vaccination may significantly reduce the risk of recurrences. 
Therefore it is worthwhile investigating whether influenza vaccination in children with a first 
febrile seizure has a preventive effect on recurrences and, hopefully, on subsequent 
unprovoked seizures. An outcome that furthermore deserves investigation is the rapidly 
growing support for a role of innate immunity in febrile seizures. As we do not know yet 
which part of the immune response is involved, the role of innate immunity in febrile seizures 
needs further dissection. Although it is difficult to predict what future benefits will result from 
such investigations, they may lead to preventive measures as well. 
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HOE ONTSTAAN KOORTSSTUIPEN? 
 
Dit is kort gezegd de belangrijkste vraag die in dit proefschrift zou moeten worden 
beantwoord. Een koortsstuip is de meest voorkomende epileptische aandoening op de 
kinderleeftijd, en heeft over het algemeen een goedaardig beloop. Bij ongeveer eenderde 
van alle gevallen treden echter recidieven op, en bij een klein gedeelte van de kinderen 
wordt uiteindelijk epilepsie vastgesteld, met name bij kinderen met recidief koortsstuipen. 
Hiervoor is nooit een duidelijke oorzaak vastgesteld, waardoor een gunstige afloop niet bij 
voorbaat vaststaat. Hoewel koorts een absolute voorwaarde is voor de vaststelling van een 
koortsstuip, is het onwaarschijnlijk dat koorts als enige verantwoordelijk is voor het ontstaan 
van koortsstuipen. Vaak wordt bij kinderen met koortsstuipen een virusinfectie vastgesteld, 
waardoor een direct of indirect verband met een dergelijke infectie vaak is gesuggereerd. De 
ontdekking van de humane herpesvirussen type 6 (HHV-6) en type 7 (HHV-7), waarvan is 
aangetoond dat deze in de hersenen kunnen doordringen en frequent geassocieerd zijn met 
koortsstuipen, heeft geleid tot een hernieuwde discussie over de betekenis van virusinfecties 
in de hersenen. Kunnen koortsstuipen ontstaan middels het binnendringen van virussen in 
het centraal zenuwstelsel (CZS), of door reactivatie van reeds in het CZS aanwezige 
virussen? Deze vraag stond centraal bij aanvang van ons onderzoek, en vormde de 
aanleiding om onderzoek te doen naar de rol van (virus)infecties bij kinderen met 
koortsstuipen, met name ten aanzien van de aanwezigheid van deze verwekkers in 
hersenvocht (liquor). 
 
Hoofdstuk 1 beschrijft in korte lijnen het doel van het onderzoek, alsmede de opzet van dit 
proefschrift. Doel van het onderzoek was (1) vaststellen welke verwekkers betrokken zijn bij 
koortsstuipen, (2) of deze verwekkers zich tijdens koortsstuipen in de liquor bevinden, (3) het 
onderzoeken van de mogelijkheid van reactivatie van HHV-6 en HHV-7 in de hersenen, en 
(4) nagaan of bepaalde ziekteverwekkers in het bijzonder bijdragen aan recidief 
koortsstuipen.  
Hoofdstuk 2 geeft een literatuuroverzicht ten aanzien van factoren die mogelijk kunnen 
bijdragen aan het ontstaan van koortsstuipen, met name in relatie tot infecties. Ten eerste 
zijn koortsstuipen erg afhankelijk van de leeftijd, wat doet vermoeden dat er zoiets bestaat 
als een stuipdrempel, die op jonge leeftijd tijdelijk verlaagd is, en met de rijping van de 
hersenen weer stijgt. Ten tweede speelt erfelijkheid een belangrijke rol. De kans op een 
koortsstuip is hoger wanneer zich bij een eerstelijns familielid ook een koortsstuip heeft 
voorgedaan. Deze genetische predispositie is echter niet HLA afhankelijk, wat pleit tegen de 
rol van specifieke infecties of van het specifieke afweersysteem. Ten derde blijkt er een 
onbegrepen relatie te bestaan met het ontstaan van epilepsie, althans voor een gedeelte 
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van kinderen met koortsstuipen. Dit suggereert dat koortsstuipen mogelijk niet zo onschuldig 
zijn als tot nu toe werd aangenomen, of dat koortsstuipen een teken zijn van een reeds 
bestaande vatbaarheid voor epilepsie. Als vierde en laatste factor werd reeds gevonden dat 
in vergelijking met bacteriële infecties koortsstuipen veel vaker voorkomen bij virale infecties. 
Dit gegeven, dat eigenlijk hoofdthema is van dit proefschrift, suggereert enerzijds de 
mogelijkheid dat virussen de hersenen direct aantasten, of anderzijds dat een 
immuunreactie ontstaat die duidelijk verschillend is van de immuunreactie bij bacteriële 
infecties, en welke kan leiden tot een ontstekingsreactie in de hersenen. Samenvattend 
wordt gesteld dat naast een erfelijke factor virusinfecties een belangrijke rol spelen bij 
koortsstuipen. Dit kan betekenen dat preventie door middel van antivirale behandeling 
invloed zou kunnen hebben op de latere gevolgen van koortsstuipen.  
 
KOORTSSTUIPEN EN INFECTIES 
 
Hoofdstuk 3 beschrijft de resultaten van een klinische studie die werd uitgevoerd onder 
kinderen die in de Friese ziekenhuizen werden opgenomen vanwege complexe 
koortsstuipen en onder verdenking van meningitis of meningo-encefalitis. Doel van de studie 
was om na te gaan welke ziekteverwekkers bijdragen aan het ontstaan van koortsstuipen en 
of deze, als indicatie voor invasie in de hersenen, teruggevonden kunnen worden in de 
liquor. Wij waren daarbij met name geïnteresseerd in de aanwezigheid van HHV-6 en HHV-
7.  
Onze studie bevestigt de belangrijke rol van virussen. Bij 88% van in het ziekenhuis 
opgenomen kinderen konden één of meer virusinfecties worden aangetoond. Eenderde van 
de kinderen was geïnfecteerd met influenza virus. Bij eveneens éénderde van de kinderen 
werd een infectie met HHV-6 en/of HHV-7 vastgesteld. Bij een aantal van deze kinderen 
werd tevens influenza virus gevonden. Samen zorgden influenza virussen, HHV-6 en HHV-7 
voor meer dan 50% van alle virusinfecties. Opmerkelijk genoeg werden in de liquor geen 
virussen aangetoond, noch door middel van kweek, noch met behulp van moleculaire 
technieken (PCR). 
Wij concluderen dat virussen de belangrijkste oorzaak zijn van koortsstuipen, maar niet door 
middel van directe invasie en infectie van de hersenen. Naar onze mening is een indirecte, 
immunologische oorzaak veel waarschijnlijker. Deze visie wordt ondersteund door recente 
bevindingen bij zowel koortsstuipen als encefalopathie door influenza, zoals in de discussie 
van hoofdstuk 3 (en in de hoofdstukken 4 en 5) naar voren komt.  
Hoofdstuk 4 toont de resultaten van een prospectieve cohortstudie, die kon worden 
uitgevoerd dankzij de medewerking van de huisartsen in Friesland. Dit onderzoek werd 
gestart om algemene kenmerken van koortsstuipen te verzamelen van kinderen die 
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woonachtig waren in Friesland, en waarvan een gedeelte werd opgenomen in het 
ziekenhuis. Tevens onderzochten wij de relatie tussen koortsstuipen en de aanwezigheid 
van diverse virusinfecties in de algehele bevolking. Dit laatste werd gedaan door de 
incidenties van koortsstuipen te vergelijken met die van een aantal bekende virusinfecties 
die wekelijks worden verzameld door de Nederlandse Werkgroep Klinische Virologie 
(NWKV). Om een goede vergelijking mogelijk te maken met de koortsstuipen in Friesland 
werden alleen gegevens gebruikt van de drie noordelijke provincies. In deze drie provincies 
worden virusinfecties centraal onderzocht in de twee Laboratoria voor de Volksgezondheid 
in respectievelijk Leeuwarden en Groningen.  
In totaal namen 267/303 (88%) huisartsen deel aan het vier jaar durend onderzoek, hetgeen 
resulteerde in een geschatte onderzoeksduur van ca. 160.000 patiëntjaren. Daarmee 
behoort dit onderzoek wereldwijd tot één van de grootste bevolkingsstudies welke ooit m.b.t. 
koortsstuipen zijn uitgevoerd. Zowel patiëntkenmerken als kenmerken van koortsstuipen 
kwamen nauw overeen met die van eerdere studies, zoals een gering overwicht onder 
jongens (jongens : meisjes = 1,3 : 1), en een verhouding van enkelvoudige versus complexe 
koortsstuipen van 7 : 3. Vijftig procent van alle geïncludeerde kinderen kreeg zijn eerste 
koortsstuip gedurende het tweede levensjaar. De gemiddelde incidentie van koortsstuipen in 
deze onderzoeksgroep was 2,4/1000 patiëntjaren. Deze komt overeenkomt met gegevens 
uit diverse andere landen, maar is lager dan die van een andere Nederlandse studie. Omdat 
onderrapportage in onze studie niet waarschijnlijk is vermoeden wij dat zowel geografische 
verschillen, als verschil in grootte van de twee onderzochte groepen verantwoordelijk is voor 
het gevonden verschil.  
De incidentie van koortsstuipen vertoonde een duidelijke seizoensvariatie, welke in de 
statistische analyse significant geassocieerd was met influenza A. Deze relatie gold met 
name voor recidief koortsstuipen. Deze belangrijke bevinding ondersteunt onze eerdere 
waarneming zoals beschreven in hoofdstuk 3. In een recent klinisch onderzoek uit Hong 
Kong werd eveneens een relatie gevonden tussen koortsstuipen en influenza A. Nader 
onderzoek zal moeten uitwijzen in hoeverre vaccinatie tegen influenza kan bijdragen aan het 
verminderen van recidief koortsstuipen en mogelijk ook tegen het later optreden van 
epilepsie.  
Er kon geen relatie worden gevonden tussen koortsstuipen en één van de andere 
onderzochte respiratoire virussen. Dit wordt mogelijk veroorzaakt door onze relatief 
ongevoelige benadering, waarbij zowel door een lage incidentie als door een zwakke 
seizoensvariatie van andere virusinfecties een dergelijke associatie zou kunnen worden 
gemist. Dit geldt echter niet voor infecties met respiratoir syncytieel virus (RSV), die niet 
alleen de hoogste incidentie, maar ook een zeer duidelijke seizoensvariatie vertonen. 
Desondanks kon geen correlatie met koortsstuipen worden aangetoond. Als tegenhanger 
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van deze laatste bevinding wordt in hoofdstuk 6 een ziektegeschiedenis beschreven van 
een kind dat twee recidief koortsstuipen doormaakt tijdens RSV infecties. Dit illustreert naar 
ons idee dat RSV wel degelijk betrokken kan zijn bij het ontstaan van koortsstuipen doch 
niet zo frequent dat het in onze analyse kon worden aangetoond. Prospectieve studies zoals 
in hoofdstuk 6 blijven nodig om de betrokkenheid van andere “gewone” virusinfecties vast te 
stellen. Deze studie illustreert nogmaals de belangrijke bijdrage van influenza virus, dat 
ondanks de relatief lage activiteit van de laatste jaren door de toegepaste methode kon 
worden aangetoond. 
 
ENCEFALOPATHIE DOOR INFLUENZA 
 
De hiervoor beschreven belangrijke bijdrage van influenza aan koortsstuipen was door ons 
aanvankelijk niet voorzien, doch trok al snel onze aandacht. Dit kwam mede door berichten 
uit Japan, waarin melding gemaakt werd van een ernstige vorm van encefalopathie bij 
kinderen met influenza, en waarbij in een studie de mogelijke betrokkenheid van HHV-6 
en/of HHV-7 werd gesuggereerd. Een tweede studie onder Japanse kinderen kon dit echter 
niet bevestigen. Daarop zijn we zelf begonnen met het verzamelen van liquor van kinderen 
met tekenen van encefalopathie tijdens de acute fase van een influenza infectie (viruskweek 
positief).  
In Hoofdstuk 5 beschrijven wij de resultaten van een studie naar de rol van zowel influenza 
virus, als van HHV-6 en HHV-7, bij 9 Nederlandse kinderen met tekenen van encefalopathie 
tijdens influenza. Met behulp van moleculaire technieken kon echter geen influenza virus 
RNA of HHV-7 DNA in liquor worden aangetoond, terwijl bij slechts 1 kind HHV-6 DNA in de 
liquor aanwezig was. Hieruit trokken wij de conclusie dat invasie van influenza virus in de 
hersenen, noch reactivatie van HHV-6 of HHV-7 verantwoordelijk is voor de neurologische 
verschijnselen die zich tijdens influenza kunnen voordoen. Verder blijkt uit ons onderzoek 
dat encefalopathie tijdens influenza niet alleen bij Aziatische maar ook bij Kaukasische 
kinderen voorkomt, hoewel er duidelijke verschillen in de presentatie van het ziektebeeld 
lijken te bestaan. Onze studie geeft helaas onvoldoende inzicht in de incidentie van 
neurologische verschijnselen tijdens epidemische verheffingen van influenza. De 
onderzochte monsters werden slechts in twee centra verzameld (het Laboratorium voor de 
Volksgezondheid in Friesland en de afdeling medische microbiologie van het Universitair 
Medisch Centrum Nijmegen) gedurende twee opeenvolgende influenza seizoenen. De 
activiteit van influenza was tijdens deze seizoenen vrij laag. We denken dan ook dat de 
betekenis van neurologische verschijnselen tijdens influenza onderschat wordt. 
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RECIDIEF KOORTSSTUIPEN 
 
Wanneer een kind een koortsstuip heeft gehad maken ouders zich vaak ongerust over 
eventuele latere gevolgen zoals recidief koortsstuipen en epilepsie. Ongeveer éénderde van 
alle kinderen met een koortsstuip krijgt te maken met een of meer recidieven. Meer dan de 
helft van deze recidieven treedt binnen zes maanden na de eerste koortsstuip op. Zoals al 
eerder is genoemd lijken recidief koortsstuipen de kans op de latere ontwikkeling van 
epilepsie te verhogen. In Hoofdstuk 6 wordt dit geïllustreerd aan de hand van de 
ziektegeschiedenis van een kind met 3 koortsstuipen in een tijdsbestek van slechts vier 
maanden. Voor elke episode kon een virale oorzaak worden vastgesteld. De eerste 
koortsstuip trad op tijdens een infectie met parainfluenza virus, terwijl tijdens de beide 
recidieven RSV infecties werden aangetoond. Elk recidief ging gepaard met toename in 
ernst van ziekte. In het verdere verloop traden meerdere recidieven op en uiteindelijk 
ontwikkelde het kind epilepsie ondanks profylaxe die was ingesteld vanaf de vierde 
koortsstuip. De rol van virusinfecties in relatie tot de kans op een recidief koortsstuip is 
slechts in beperkte mate onderzocht. RSV en parainfluenza virus zijn nooit in relatie 
gebracht met recidieven. Daarentegen vonden wij een significante relatie tussen influenza A 
en recidief koortsstuipen (zie hoofdstuk 4), terwijl reeds eerder reactivatie door HHV-6 in de 
hersenen als mogelijke oorzaak van recidieven werd aangemerkt. Wij vermoeden dat 
bepaalde infecties niet alleen bijdragen aan een eerste koortsstuip maar ook aan recidieven. 
Daarom lijkt het ons gewenst om in plaats van de huidige symptomatische benadering van 
koortsstuipen meer aandacht te schenken aan de preventie van bepaalde virusinfecties.  
 
Er zijn diverse onderzoeken uitgevoerd naar de risicofactoren voor het krijgen van recidief 
koortsstuipen. Hieruit komt steevast naar voren dat een jonge leeftijd tijdens de eerste 
koortsstuip, een belaste familieanamnese voor koortsstuipen, alsmede hoogte en duur van 
koorts de kans op een recidief aanzienlijk verhogen. Dit was minder duidelijk voor andere 
vermoedelijke risicofactoren, zoals geslacht en type koortsstuip. In Hoofdstuk 7 worden de 
voorlopige resultaten gepresenteerd van een onderzoek naar risicofactoren voor recidief 
koortsstuipen in een gedeelte van het Friese kindercohort, dat eerder werd beschreven in 
hoofdstuk 4.  
Bij 35% van de onderzochte kinderen werden recidieven waargenomen. Zowel initiële als 
recidief koortsstuipen zijn sterk leeftijdsafhankelijk, en meer dan de helft ontstaat vóór de 
leeftijd van twee jaar. Recidieven treden in meerderheid binnen een half jaar na de eerste 
koortsstuip op (61%). Voor zowel initiële als recidief koortsstuipen geldt dat de frequentie 
aanvankelijk met de leeftijd lijkt toe te nemen, met een piek in het tweede levensjaar, waarna 
de kans weer snel afneemt. Dit patroon kan passen bij een tijdelijk verhoogde gevoeligheid 
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van de hersenen voor specifieke stimuli, welke weer afneemt met de toenemende rijping van 
de hersenen. Daarnaast suggereren wij dat dit patroon ook zou kunnen worden veroorzaakt 
door een tijdelijk verhoogde vatbaarheid voor infecties.  
Een positieve familieanamnese voor koortsstuipen en/of epilepsie was sterk gecorreleerd 
met een eerste recidief. Helaas was het niet mogelijk deze twee parameters apart te 
analyseren. Een positieve anamnese voor koortsstuipen werd in eerdere studies alleen in 
verband gebracht met een verhoogde kans op een eerste recidief, terwijl epilepsie in de 
familie de kans op zowel koortsstuipen als epilepsie zou verhogen. Hieruit zou men kunnen 
opmaken dat aan deze twee ziektebeelden verschillende mechanismen ten grondslag 
liggen.  
Een atypisch of complex beloop van de initiële koortsstuip was gecorreleerd met een 
verhoogd risico op een tweede recidief. In de literatuur zijn de meningen hierover nogal 
verdeeld. Slechts onderzoek in de algehele bevolking lijkt een dergelijke risicofactor naar 
voren te kunnen brengen.  
Tenslotte bleek een kort tijdsverloop tussen een initiële koortsstuip en een eerste recidief 
duidelijk gecorreleerd te zijn met een tweede recidief koortsstuip. Mogelijk is deze bevinding 
echter weer afhankelijk van de leeftijd.  
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RESUMÉ EN TOEKOMSTVISIE 
 
Samenvattend kan worden gesteld dat virale infecties de belangrijkste oorzaak zijn van 
koortsstuipen, met name infecties door influenza A, HHV-6 en HHV-7. Tevens is gebleken 
dat bepaalde virale infecties duidelijk bijdragen aan zowel initiële koortsstuipen als 
recidieven. Virussen konden niet in de liquor worden aangetoond, waardoor het 
onwaarschijnlijk is dat directe invasie en infectie van de hersenen een belangrijke rol spelen 
in het ontstaan van koortsstuipen. Ons onderzoek sluit aan bij de conclusie dat koorts op 
zich niet verantwoordelijk is voor het ontstaan van koortsstuipen, mede door het feit dat 
profylaxe met koortswerende middelen geen bescherming biedt tegen het ontstaan van 
recidieven. Als oorzaak moet daarom aan een ander, meer indirect werkend mechanisme 
worden gedacht. Cytokinen lijken daarbij een belangrijke rol te spelen.  
Hoewel recidief koortsstuipen gepaard gaan met een verhoogd risico op het later ontstaan 
van epilepsie, is het mechanisme hiervan niet bekend. Een dergelijk inzicht zou echter van 
groot belang kunnen zijn voor de preventie van epilepsie.  
Het feit dat influenza A gecorreleerd blijkt te zijn met recidief koortsstuipen biedt de 
mogelijkheid om na te gaan of influenza vaccinatie bij kinderen na een eerste koortsstuip 
een vermindering geeft van recidief koortsstuipen, en hopelijk ook van epilepsie. Verder lijkt 
er een belangrijke rol weggelegd voor het eigen immuun systeem. Omdat niet duidelijk is 
welk deel van de immunologische respons betrokken is bij het ontstaan van koortsstuipen, is 
nader onderzoek naar de specifieke rol van immunologische processen bij koortsstuipen 
zeer wenselijk. 
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behaalt het doctoraal examen in 1984,
waarna het artsexamen volgt in 1985. 
Aansluitend is hij gedurende anderhalf
jaar werkzaam als arts-assistent
Inwendige Geneeskunde (Merwede
Ziekenhuis te Dordrecht), waarna hij
arts-assistent wordt op de afdeling
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Academisch Ziekenhuis te Rotterdam
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aanvang (opleider: Prof. Dr. M.F. Michel). 
Na voltooiing van de opleiding wordt hij
per 1 juli 1991 ingeschreven in het speci-
alistenregister en begint hij als arts-
microbioloog in het St. Laurentius
Ziekenhuis in Roermond. Vanaf juni
1992 wordt de praktijk uitgebreid met
werkzaamheden in het St. Jans Gasthuis
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Sionsberg in Dokkum. 
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